{"content":"<li class=\"n-box-item date-title\" data-end=\"1537243199\" data-start=\"1537156800\" data-txt=\"Monday, December 23, 2019\">Monday, September 17, 2018</li><li class=\"n-box-item sa-box-item\" data-id=\"3390930\" data-ts=\"1537221567\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FDX\" target=\"_blank\">FDX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3390930-fedexminus-2-after-sharp-earnings-miss-raises-full-year-2019-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FedEx -2% after sharp earnings miss; raises full-year 2019 guidance</a></h4><ul>     <li>FedEx (NYSE:<a href='https://seekingalpha.com/symbol/FDX' title='FedEx Corporation'>FDX</a>) <font color='red'>-2.2%</font> after-hours after missing <a href=\"https://seekingalpha.com/news/3390878-fedex-misses-0_36-beats-revenue\" target=\"_blank\">Q1 earnings</a> estimates despite reporting higher than expected revenue and raising its FY 2019 outlook.</li>     <li>FDX says it recognized substantially higher variable compensation accruals during the quarter, and during the previous quarter the company accelerated wage increases for certain hourly employees due to the enactment of U.S. tax cuts; FDX says the combined impact negatively affected Y/Y results by $170M, or $0.48/share.</li>     <li>&ldquo;We are very optimistic about our prospects for profitable growth and remain confident we will reach our goal to improve FedEx Express operating income by $1.2B-$1.5B in fiscal 2020 vs. fiscal 2017,&rdquo; says CEO Fred Smith.</li>     <li>As a result, FDX raises its adjusted EPS to $15.85-$16.45 from the previous range of $15.65-$16.25, including TNT Express integration expenses, based on stability in global trade.</li>     <li>In its post-earnings conference call, FDX says it is starting to see signs of&nbsp; moderating economic activity in China due to the tariffs.</li></ul><div class=\"tiny-share-widget\" data-id=\"3390930\" data-linked=\"FedEx -2% after sharp earnings miss; raises full-year 2019 guidance\" data-tweet=\"$FDX - FedEx -2% after sharp earnings miss; raises full-year 2019 guidance https://seekingalpha.com/news/3390930-fedexminus-2-after-sharp-earnings-miss-raises-full-year-2019-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3390930-fedexminus-2-after-sharp-earnings-miss-raises-full-year-2019-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:59 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3390929\" data-ts=\"1537220756\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RDCM\" target=\"_blank\">RDCM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3390929-radcom-schedules-call-after-29-slide-in-typhoons-wake\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Radcom schedules call after 29% slide in typhoon&#39;s wake</a></h4><ul>   <li>Israel-based comm tech service provider Radcom (NASDAQ:<a href='https://seekingalpha.com/symbol/RDCM' title='Radcom Ltd.'>RDCM</a>) plans a <a href=\"https://seekingalpha.com/pr/17272081-radcom-hold-conference-call-tuesday-september-18-2018\" target=\"_blank\">conference call</a> for tomorrow, likely to update investors after it suffered its worst day at the markets in five years.</li>    <li>Shares closed <font color='red'>down 29%</font> in the aftermath of Super Typhoon Mangkhut, which hit the Philippines hard last week.</li>    <li>Filipino firm Globe Telecom (<a href='https://seekingalpha.com/symbol/GTMEY' title='Globe Telecom, Inc. ADR'>OTCPK:GTMEY</a>) makes up 34% of Radcom's revenue, as its second-biggest customer.</li>    <li>Radcom's call is coming tomorrow morning at 8 a.m. ET.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3390840-radcom-tumbles-33-percent-customer-exposure-typhoon\" target=\"_blank\">Radcom tumbles more than 33% on customer exposure to typhoon</a> (Sep. 17 2018)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3390929\" data-linked=\"Radcom schedules call after 29% slide in typhoon&#39;s wake\" data-tweet=\"$RDCM $RDCM $GTMEY - Radcom schedules call after 29% slide in typhoon&#39;s wake https://seekingalpha.com/news/3390929-radcom-schedules-call-after-29-slide-in-typhoons-wake?source=tweet\" data-url=\"https://seekingalpha.com/news/3390929-radcom-schedules-call-after-29-slide-in-typhoons-wake\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:45 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3390927\" data-ts=\"1537220121\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WES\" target=\"_blank\">WES</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3390927-after-hours-gainers-losers-09-17-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers (09/17/2018)</a></h4><ul><li><b>Top Gainers:</b> <a href='https://seekingalpha.com/symbol/WES' title='Western Gas Partners, L.P.'>WES</a> <font color='green'>+4.9%</font>. <a href='https://seekingalpha.com/symbol/CRK' title='Comstock Resources Inc.'>CRK</a> <font color='green'>+3.8%</font>. <a href='https://seekingalpha.com/symbol/IAG' title='IAMGOLD Corporation'>IAG</a> <font color='green'>+2.6%</font>. <a href='https://seekingalpha.com/symbol/CVM' title='Cel-Sci Corporation'>CVM</a> <font color='green'>+1.6%</font>.</li><li><b>Top Losers:</b> <a href='https://seekingalpha.com/symbol/ORCL' title='Oracle Corporation'>ORCL</a> <font color='red'>-4.2%</font>. <a href='https://seekingalpha.com/symbol/FDX' title='FedEx Corporation'>FDX</a>&nbsp;<font color='red'>-3.9%</font>. <a href='https://seekingalpha.com/symbol/ARGX' title='Argenx SE'>ARGX</a> <font color='red'>-3.5%</font>. <a href='https://seekingalpha.com/symbol/NIO' title='NIO'>NIO</a> <font color='red'>-3.4%</font>. <a href='https://seekingalpha.com/symbol/BPMP' title='BP Midstream Partners LP'>BPMP</a> <font color='red'>-3.1%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3390927\" data-linked=\"After Hours Gainers / Losers (09/17/2018)\" data-tweet=\"$WES $WES $CRK - After Hours Gainers / Losers (09/17/2018) https://seekingalpha.com/news/3390927-after-hours-gainers-losers-09-17-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3390927-after-hours-gainers-losers-09-17-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:35 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3390924\" data-ts=\"1537219180\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ORCL\" target=\"_blank\">ORCL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3390924-oracle-guides-downside-q2-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oracle guides downside Q2 revenue</a></h4><ul><li>        Oracle (NYSE:<a href='https://seekingalpha.com/symbol/ORCL' title='Oracle Corporation'>ORCL</a>) provides Q2 guidance on the earnings call with revenue growth expected from flat to 2% in constant currency due to the &ldquo;tough comparison.&rdquo; The growth would put revenue from about $9.21B to $9.4B (consensus: $9.82B).</li><li>               Oracle expects revenue in 2H to be higher.&nbsp;</li><li>               EPS is expected from $0.79 to $0.80 (consensus: $0.79). The company expects double-digit EPS growth in FY19.&nbsp;</li><li>                  Oracle shares are&nbsp;<font color='red'>down 4.2%</font>&nbsp;to $47.20.&nbsp; </li><li>Previously: <a href=\"https://seekingalpha.com/news/3390883-oracle-minus-4_5-percent-mixed-q1-cloud-services-misses-consensus\" target=\"_blank\">Oracle -4.5% on mixed Q1, Cloud Services misses consensus</a> (Sept. 17)</li></ul><div class=\"tiny-share-widget\" data-id=\"3390924\" data-linked=\"Oracle guides downside Q2 revenue\" data-tweet=\"$ORCL - Oracle guides downside Q2 revenue https://seekingalpha.com/news/3390924-oracle-guides-downside-q2-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3390924-oracle-guides-downside-q2-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:19 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3390922\" data-ts=\"1537219083\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NUACF\" target=\"_blank\">NUACF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3390922-avonplus-15-on-report-of-natura-takeover-approach\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Avon +15% on report of Natura takeover approach</a></h4><ul>   <li>Brazil's Natura Cosmeticos (<a href='https://seekingalpha.com/symbol/NUACF' title='Natura Cosmeticos SA'>OTC:NUACF</a>) recently <a href=\"https://www.wsj.com/articles/brazils-natura-recently-approached-avon-about-a-takeover-1537217957?mod=hp_lista_pos4\" target=\"_blank\">approached Avon Products</a> (NYSE:<a href='https://seekingalpha.com/symbol/AVP' title='Avon Products, Inc.'>AVP</a>) about a takeover, <i>The Wall Street Journal</i> reports, though its says the talks aren't serious.</li>    <li>Avon shares have jumped after hours, <font color='green'>up 15.4%</font>.</li>    <li>They aren't the only overtures Avon has received, according to the report, but the company is focused on its on turnaround.</li>    <li>Natura, Brazil's biggest cosmetics company, says there \"no negotiations in progress\" regarding a possible Avon deal. It runs a direct sales force similar to that of Avon.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3390922\" data-linked=\"Avon +15% on report of Natura takeover approach\" data-tweet=\"$NUACF $NUACF $AVP - Avon +15% on report of Natura takeover approach https://seekingalpha.com/news/3390922-avonplus-15-on-report-of-natura-takeover-approach?source=tweet\" data-url=\"https://seekingalpha.com/news/3390922-avonplus-15-on-report-of-natura-takeover-approach\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:18 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3390883\" data-ts=\"1537215757\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ORCL\" target=\"_blank\">ORCL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3390883-oracleminus-4_5-on-mixed-q1-cloud-services-misses-consensus\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oracle -4.5% on mixed Q1, Cloud Services misses consensus</a></h4><ul><li>        Oracle (NYSE:<a href='https://seekingalpha.com/symbol/ORCL' title='Oracle Corporation'>ORCL</a>)&nbsp;<font color='red'>drops 4.5%</font>&nbsp;aftermarket on Q1 results that beat on EPS but missed on revenue.</li><li>               Revenue breakdown: Cloud Services and License Support revenue was $6.6B (consensus: $6.68B). Cloud License and On-Premise License revenue totaled $867M (consensus: $863M). Those performances added together amounted to $7.5B, up 2% Y/Y. Hardware sales were $904M (consensus: $876M) and Services reported $813M (consensus: $827.1M).&nbsp;</li><li>               Share authorization: Board increases the share repurchase authorization by $12B.&nbsp;</li><li>               Earnings call is scheduled for 5 PM Eastern with webcast available <a href=\"http://investor.oracle.com/overview/highlights/default.aspx\" target=\"_blank\">here</a>.&nbsp;</li><li>               <a href=\"https://seekingalpha.com/pr/17272077-q1-fy19-gaap-eps-13-percent-0_57-non-gaap-eps-18-percent-0_71\" target=\"_blank\">Press release.</a>&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3390862-oracle-beats-0_02-misses-revenue\" target=\"_blank\">Oracle beats by $0.02, misses on revenue</a> (Sept. 17)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3390867-oracle-declares-0_19-dividend\" target=\"_blank\">Oracle declares $0.19 dividend</a> (Sept. 17)</li></ul><div class=\"tiny-share-widget\" data-id=\"3390883\" data-linked=\"Oracle -4.5% on mixed Q1, Cloud Services misses consensus\" data-tweet=\"$ORCL - Oracle -4.5% on mixed Q1, Cloud Services misses consensus https://seekingalpha.com/news/3390883-oracleminus-4_5-on-mixed-q1-cloud-services-misses-consensus?source=tweet\" data-url=\"https://seekingalpha.com/news/3390883-oracleminus-4_5-on-mixed-q1-cloud-services-misses-consensus\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:22 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3390866\" data-ts=\"1537215072\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MFIN\" target=\"_blank\">MFIN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3390866-medallion-financial-submits-materials-for-medallion-bank-preferred-stock-ipo\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Medallion Financial submits materials for Medallion Bank preferred stock IPO</a></h4><ul><li>Medallion Financial's (NASDAQ:<a href='https://seekingalpha.com/symbol/MFIN' title='Medallion Financial'>MFIN</a>) Medallion Bank subsidiary <a href=\"https://seekingalpha.com/pr/17272070-medallion-financial-corp-announces-medallion-bank-s-planned-public-offering-preferred-stock\" target=\"_blank\">submits confidential draft offering materials </a>to the Federal Deposit Insurance Corp. for an anticipated initial public offering of a series of preferred stock.</li><li>MFIN<font color='green'> +1.07%</font>&nbsp;in after-hours trading.</li><li>Timing, size, and other terms of the offering haven't been determined.</li><li>Medallion Bank will remain a wholly owned subsidiary of Medallion Financial.</li><li>If completed MFIN expects the offering to be accretive for Medallion Bank and Medallion Financial.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3382194-medallion-financial-q2-continues-shift-away-medallion-lending\" target=\"_blank\">More on Medallion Financial Q2: Continues shift away from medallion lending</a> (Aug. 13)</li></ul><div class=\"tiny-share-widget\" data-id=\"3390866\" data-linked=\"Medallion Financial submits materials for Medallion Bank preferred stock IPO\" data-tweet=\"$MFIN - Medallion Financial submits materials for Medallion Bank preferred stock IPO https://seekingalpha.com/news/3390866-medallion-financial-submits-materials-for-medallion-bank-preferred-stock-ipo?source=tweet\" data-url=\"https://seekingalpha.com/news/3390866-medallion-financial-submits-materials-for-medallion-bank-preferred-stock-ipo\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:11 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3390853\" data-ts=\"1537214322\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VVV\" target=\"_blank\">VVV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3390853-valvoline-upgraded-to-buy-seaport-last-weeks-selloff-overblown\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Valvoline upgraded to Buy at Seaport, as last week&#39;s selloff &#39;overblown&#39;</a></h4><ul>     <li>Valvoline (<a href='https://seekingalpha.com/symbol/VVV' title='Valvoline, Inc'>VVV</a> <font color='green'>+3.3%</font>) is sharply higher after Seaport Global <a href=\"https://www.streetinsider.com/Analyst+Comments/Seaport+Global+Securities+Upgrades+Valvoline+%28VVV%29+to+Buy/14612502.html\" target=\"_blank\">upgrades shares to Buy</a> from Neutral with a $25 price target, believing <a href=\"https://seekingalpha.com/news/3390355-valvoline-drops-amazon-anxiety\" target=\"_blank\">last week's selloff</a> was overblown and provides an opportunity for investors to join in the growth story driven by Quick Lubes and International.</li><li>Seaport says reaction to concerns about Amazon's private-label competition were overdone as cheaper alternatives already exist.</li><li>The firm also expects normalizing trends in VVV's core North American segment in Q4, noting base oil prices appear to be stabilizing, which should  help the company catch up on the price/cost front.</li><li>Seaport also continues to see announcements that VVV is adding stores to its quick-lube network and believes there is plenty of runway for additional store count growth.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3390853\" data-linked=\"Valvoline upgraded to Buy at Seaport, as last week&#39;s selloff &#39;overblown&#39;\" data-tweet=\"$VVV - Valvoline upgraded to Buy at Seaport, as last week&#39;s selloff &#39;overblown&#39; https://seekingalpha.com/news/3390853-valvoline-upgraded-to-buy-seaport-last-weeks-selloff-overblown?source=tweet\" data-url=\"https://seekingalpha.com/news/3390853-valvoline-upgraded-to-buy-seaport-last-weeks-selloff-overblown\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:58 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3390852\" data-ts=\"1537214314\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MHLD\" target=\"_blank\">MHLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3390852-maiden-holdings-slides-15\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Maiden Holdings slides 15%</a></h4><ul><li>Maiden Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/MHLD' title='Maiden Hldgs Ltd'>MHLD</a>)&nbsp;<font color='red'>slumps 15%</font>&nbsp;in late trading, making it the fourth biggest loser on NYSE and Nasdaq, with no obvious catalyst.</li><li>On Friday afternoon,<a href=\"https://seekingalpha.com/filing/4170511\" target=\"_blank\">&nbsp;Catalina Holdings disclosed</a> it increased its stake in Maiden by 2.48M shares, bringing its total holdings to 6.64M shares, or 7.99% of MHLD's total shares outstanding.</li><li>On Sept. 12, Catalina purchased 2.02M shares at $2.271 each and the next day bought 460,000 shares at $2.469 per share.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3388792-maiden-holdings-sinks-filing-discloses-cfo-departure-mrna-details\" target=\"_blank\">Maiden Holdings sinks; filing discloses CFO departure, MRNA details</a> (Sept. 7)</li></ul><div class=\"tiny-share-widget\" data-id=\"3390852\" data-linked=\"Maiden Holdings slides 15%\" data-tweet=\"$MHLD - Maiden Holdings slides 15% https://seekingalpha.com/news/3390852-maiden-holdings-slides-15?source=tweet\" data-url=\"https://seekingalpha.com/news/3390852-maiden-holdings-slides-15\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:58 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3390849\" data-ts=\"1537213119\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ATXI\" target=\"_blank\">ATXI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3390849-avenue-therapeutics-down-15\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Avenue Therapeutics down 15%</a></h4><ul><li>Thinly traded nano cap Avenue Therapeutics (<a href='https://seekingalpha.com/symbol/ATXI' title='Avenue Therapeutics'>ATXI</a> <font color='red'>-15.2%</font>) slumps on more than double normal volume, albeit on turnover of only 43K shares. The stock has corrected over&nbsp;<font color='red'>25%</font>&nbsp;since reporting Q2 results on August 14.</li><li>On the working capital front, at the end of June it had $9.4M in cash and equivalents while operations consumed $12.8M in H1.</li></ul><div class=\"tiny-share-widget\" data-id=\"3390849\" data-linked=\"Avenue Therapeutics down 15%\" data-tweet=\"$ATXI - Avenue Therapeutics down 15% https://seekingalpha.com/news/3390849-avenue-therapeutics-down-15?source=tweet\" data-url=\"https://seekingalpha.com/news/3390849-avenue-therapeutics-down-15\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:38 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3390840\" data-ts=\"1537211026\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RDCM\" target=\"_blank\">RDCM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3390840-radcom-tumbles-33-on-customer-exposure-to-typhoon\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Radcom tumbles more than 33% on customer exposure to typhoon</a></h4><ul><li>The Philippines' Global Telecom accounted for 34% of Radcom's (<a href='https://seekingalpha.com/symbol/RDCM' title='Radcom Ltd.'>RDCM</a> <font color='red'>-33%</font>) Q2 revenue, making it the company's 2nd-largest customer.</li><li>The Philippines last week was slammed by Super Typhoon Mangkhut.</li><li>Source: Bloomberg</li></ul><div class=\"tiny-share-widget\" data-id=\"3390840\" data-linked=\"Radcom tumbles more than 33% on customer exposure to typhoon\" data-tweet=\"$RDCM - Radcom tumbles more than 33% on customer exposure to typhoon https://seekingalpha.com/news/3390840-radcom-tumbles-33-on-customer-exposure-to-typhoon?source=tweet\" data-url=\"https://seekingalpha.com/news/3390840-radcom-tumbles-33-on-customer-exposure-to-typhoon\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:03 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>59&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3390839\" data-ts=\"1537210937\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AWSM\" target=\"_blank\">AWSM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3390839-technology-top-5-gainers-losers-of-3_00-pm-09-17-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top 5 Gainers / Losers as of 3.00 PM (09/17/2018)</a></h4><ul>     <li><strong>Gainers:</strong> <a href='https://seekingalpha.com/symbol/AWSM' title='Cool Holdings Inc.'>AWSM</a> <font color='green'>+42%</font>. <a href='https://seekingalpha.com/symbol/RFIL' title='RF Industries, Ltd.'>RFIL</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/QTM-OLD' title='Quantum Corporation'>QTM-OLD</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/DGLY' title='Digital Ally, Inc.'>DGLY</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/SPA' title='Sparton Corporation'>SPA</a> <font color='green'>+10%</font>.</li>     <li><strong>Losers:</strong> <a href='https://seekingalpha.com/symbol/QTT' title='Qutoutiao'>QTT</a> <font color='red'>-36%</font>. <a href='https://seekingalpha.com/symbol/RDCM' title='Radcom Ltd.'>RDCM</a> <font color='red'>-33%</font>. <a href='https://seekingalpha.com/symbol/HMNY' title='Helios and Matheson Analytics, Inc.'>HMNY</a> <font color='red'>-29%</font>. <a href='https://seekingalpha.com/symbol/RENN' title='Renren Inc.'>RENN</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/LINK' title='Interlink Electronics'>LINK</a> <font color='red'>-15%</font>.</li> &nbsp; </ul><div class=\"tiny-share-widget\" data-id=\"3390839\" data-linked=\"Technology - Top 5 Gainers / Losers as of 3.00 PM (09/17/2018)\" data-tweet=\"$AWSM $AWSM $RFIL - Technology - Top 5 Gainers / Losers as of 3.00 PM (09/17/2018) https://seekingalpha.com/news/3390839-technology-top-5-gainers-losers-of-3_00-pm-09-17-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3390839-technology-top-5-gainers-losers-of-3_00-pm-09-17-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:02 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3390837\" data-ts=\"1537210854\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ETSY\" target=\"_blank\">ETSY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3390837-online-retail-jolted-amazon-small-business-play\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Online retail jolted by Amazon small business play</a></h4><ul> <li>Etsy (<a href='https://seekingalpha.com/symbol/ETSY' title='Etsy, Inc.'>ETSY</a> <font color='red'>-4.9%</font>), Wayfair (<a href='https://seekingalpha.com/symbol/W' title='Wayfair'>W</a> <font color='red'>-3.2%</font>), 1-800 Flowers.com (<a href='https://seekingalpha.com/symbol/FLWS' title='1-800 FLOWERS.COM, Inc.'>FLWS</a> <font color='red'>-7.8%</font>) and Overstock.com (<a href='https://seekingalpha.com/symbol/OSTK' title='Overstock.com, Inc.'>OSTK</a> <font color='red'>-4.6%</font>) are sharply lower after Amazon (<a href='https://seekingalpha.com/symbol/AMZN' title='Amazon.com, Inc.'>AMZN</a> <font color='red'>-2.6%</font>) launches a new small business section on its website called <a href=\"https://www.amazon.com/b?node=17879387011&amp;tag=googhydr-20&amp;hvadid=294901176460&amp;hvpos=1t1&amp;hvexid=&amp;hvnetw=g&amp;hvrand=6440583573727745265&amp;hvpone=&amp;hvptwo=&amp;hvqmt=b&amp;hvdev=c&amp;ref=pd_sl_3qteo3akjc_b&amp;hvtargid=kwd-518399722686\" target=\"_blank\">Amazon Storefronts.</a></li> <li>The new page features over 1M products from almost 20K small and medium-sized businesses in the U.S.</li><li>Related ETF: <a href='https://seekingalpha.com/symbol/IBUY' title='Amplify Online Retail ETF'>IBUY</a>.</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3390837\" data-linked=\"Online retail jolted by Amazon small business play\" data-tweet=\"$ETSY $ETSY $W - Online retail jolted by Amazon small business play https://seekingalpha.com/news/3390837-online-retail-jolted-amazon-small-business-play?source=tweet\" data-url=\"https://seekingalpha.com/news/3390837-online-retail-jolted-amazon-small-business-play\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>27&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3390835\" data-ts=\"1537210424\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CI\" target=\"_blank\">CI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3390835-cigna-express-scripts-deal-greenlit-doj\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cigna/Express Scripts deal greenlit by DOJ</a></h4><ul><li>Headlines are out saying the DOJ has cleared Cigna's (NYSE:<a href='https://seekingalpha.com/symbol/CI' title='Cigna Corporation'>CI</a>) purchase of Express Scripts (NASDAQ:<a href='https://seekingalpha.com/symbol/ESRX' title='Express Scripts, Inc.'>ESRX</a>).</li><li>ESRX has&nbsp;<font color='green'>popped 4%&nbsp;</font>in the past few moments.</li><li>\"We are pleased that the Department of Justice has cleared our transaction and that we are another step closer to completing our merger and delivering greater affordability, choice and predictability to our customers and clients as a combined company,\" <a href=\"https://seekingalpha.com/pr/17271995-u-s-department-justice-grants-clearance-cigna-s-acquisition-express-scripts\" target=\"_blank\">says Cigna CEO David Cordani</a>.</li><li>The companies continue to anticipate closing prior to year-end.</li></ul><div class=\"tiny-share-widget\" data-id=\"3390835\" data-linked=\"Cigna/Express Scripts deal greenlit by DOJ\" data-tweet=\"$CI $CI $ESRX - Cigna/Express Scripts deal greenlit by DOJ https://seekingalpha.com/news/3390835-cigna-express-scripts-deal-greenlit-doj?source=tweet\" data-url=\"https://seekingalpha.com/news/3390835-cigna-express-scripts-deal-greenlit-doj\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:53 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3390828\" data-ts=\"1537208676\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AAPL\" target=\"_blank\">AAPL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3390828-bloomberg-apple-watch-excluded-from-latest-tariffs\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bloomberg: Apple Watch excluded from latest tariffs</a></h4><ul><li>Apple&rsquo;s (NASDAQ:<a href='https://seekingalpha.com/symbol/AAPL' title='Apple Inc.'>AAPL</a>) Watch and AirPods will be spared in the latest round of proposed tariffs on China, according to <a href=\"https://www.bloomberg.com/news/articles/2018-09-17/trump-set-to-slap-10-tariff-on-200-billion-of-chinese-goods\" target=\"_blank\">Bloomberg sources.</a></li><li>Earlier this month, Apple revealed that the tariffs on $200B of Chinese good would hit the Watch, AirPods, and the adapters and chargers for a range of products.</li><li>Apple shares are&nbsp;<font color='red'>down 1.7%</font>&nbsp;to $219.97.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3388862-apple-suppliers-drop-talks-tariff-impact\" target=\"_blank\">Apple, suppliers drop on talks of tariff impact</a> (Sept. 7)</li><li>Post updated to include AirPods in the possible exemption.</li></ul><div class=\"tiny-share-widget\" data-id=\"3390828\" data-linked=\"Bloomberg: Apple Watch excluded from latest tariffs\" data-tweet=\"$AAPL - Bloomberg: Apple Watch excluded from latest tariffs https://seekingalpha.com/news/3390828-bloomberg-apple-watch-excluded-from-latest-tariffs?source=tweet\" data-url=\"https://seekingalpha.com/news/3390828-bloomberg-apple-watch-excluded-from-latest-tariffs\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:24 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>98&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3390824\" data-ts=\"1537207310\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SNMX\" target=\"_blank\">SNMX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3390824-energy-materials-top-gainers-losers-of-2-00-pm-09-17-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top Gainers / Losers as of 2:00 PM (09/17/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/SNMX' title='Senomyx, Inc.'>SNMX</a> <font color='green'>+41%</font>. <a href='https://seekingalpha.com/symbol/SES' title='Synthesis Energy Systems, Inc.'>SES</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/FF' title='FutureFuel Corp.'>FF</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/LEU' title='Centrus Energy Corp.'>LEU</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/TAHO' title='Tahoe Resources Inc.'>TAHO</a> <font color='green'>+10%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/BPT' title='BP Prudhoe Bay Royalty Trust'>BPT</a> <font color='red'>-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3390824\" data-linked=\"Energy/Materials - Top Gainers / Losers as of 2:00 PM (09/17/2018)\" data-tweet=\"$SNMX $SNMX $SES - Energy/Materials - Top Gainers / Losers as of 2:00 PM (09/17/2018) https://seekingalpha.com/news/3390824-energy-materials-top-gainers-losers-of-2-00-pm-09-17-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3390824-energy-materials-top-gainers-losers-of-2-00-pm-09-17-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:01 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3390823\" data-ts=\"1537207253\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TPCO\" target=\"_blank\">TPCO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3390823-tronc-mcclatchy-higher-amid-merger-talk-reports\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tronc, McClatchy higher amid merger talk reports</a></h4><ul>   <li>Tronc (<a href=\"http://seekingalpha.com/symbol/TRNC\" target=\"_blank\">TRNC</a> <font color='green'>+0.8%</font>) is paring some early gains today in the wake of weekend reports that it's engaged in early-stage talks for an <a href=\"http://www.latimes.com/business/la-fi-tronc-mcclatchy-20180915-story.html\" target=\"_blank\">acquisition by McClatchy</a> (<a href=\"http://seekingalpha.com/symbol/MNI\" target=\"_blank\">MNI</a> <font color='green'>+1.9%</font>), joining a pursuit that also includes the Donerail Group.</li>    <li>McClatchy owns more than 30 newspapers in 14 states; taking over Tronc would get it the <i>Chicago Tribune</i> as well as the <i>Baltimore Sun,</i> the <i>New York Daily News</i> and several other papers.</li>    <li>The Donerail Group is headed by Will Wyatt, who's reportedly offered $19-$20/share for Tronc. Shares are currently at $16.27.</li>    <li>Wyatt was a paid consultant in Tronc's $500M sale of the <i>Los Angeles Times</i> and <i>San Diego Union-Tribune</i> to billionaire Patrick Soon-Shiong this summer.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3380301-tronc-plus-16-percent-reportedly-considers-divesting-newspapers\" target=\"_blank\">Tronc +16% as it reportedly considers divesting all newspapers</a> (Aug. 08 2018)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3364683-tronc-closes-l-times-sale-change-name-back\" target=\"_blank\">Tronc closes L.A. Times sale; to change name back</a> (Jun. 18 2018)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3328942-tronc-confirms-500m-la-sd-newspaper-sales-shares-plus-27-percent\" target=\"_blank\">Tronc confirms $500M LA, SD newspaper sales; shares +27%</a> (Feb. 07 2018)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3390823\" data-linked=\"Tronc, McClatchy higher amid merger talk reports\" data-tweet=\"$TPCO $TPCO $MNI - Tronc, McClatchy higher amid merger talk reports https://seekingalpha.com/news/3390823-tronc-mcclatchy-higher-amid-merger-talk-reports?source=tweet\" data-url=\"https://seekingalpha.com/news/3390823-tronc-mcclatchy-higher-amid-merger-talk-reports\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3390822\" data-ts=\"1537207223\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TGTX\" target=\"_blank\">TGTX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3390822-tg-therapeutics-continues-selloff-shares-down-9\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">TG Therapeutics continues selloff, shares down 9%</a></h4><ul><li>TG Therapeutics (<a href='https://seekingalpha.com/symbol/TGTX' title='TG Therapeutics, Inc.'>TGTX</a> <font color='red'>-8.8%</font>) continues its slide on modestly higher volume. Shares have sold off over&nbsp;<font color='red'>22%</font>&nbsp;this month as investors appear skittish over the pending release of topline response data from its Phase 3 <a href=\"https://clinicaltrials.gov/ct2/show/NCT02612311?lead=tg+therapeutics&amp;phase=2&amp;rank=3\" target=\"_blank\">UNITY-CLL</a> study evaluating ublituximab + umbralisib (called \"U2\") in patients with chronic lymphocytic leukemia &#40;CLL&#41;.</li><li>The company says it is targeting a 15% absolute improvement in overall response rate compared to the active control arm of Roche's GAZYVA (obinutuzumab) plus the chemo agent chlorambucil. The data are supposed to be released by the \"end of the summer.\"</li></ul><div class=\"tiny-share-widget\" data-id=\"3390822\" data-linked=\"TG Therapeutics continues selloff, shares down 9%\" data-tweet=\"$TGTX - TG Therapeutics continues selloff, shares down 9% https://seekingalpha.com/news/3390822-tg-therapeutics-continues-selloff-shares-down-9?source=tweet\" data-url=\"https://seekingalpha.com/news/3390822-tg-therapeutics-continues-selloff-shares-down-9\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>41&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3390816\" data-ts=\"1537205672\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OPK\" target=\"_blank\">OPK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3390816-bargain-hunters-move-opko-health-shares-ahead-16\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bargain hunters move into Opko Health, shares ahead 16%</a></h4><ul><li>OPKO Health (<a href='https://seekingalpha.com/symbol/OPK' title='OPKO Health, Inc.'>OPK</a> <font color='green'>+15.6%</font>) is up on double normal volume as bargain hunters grab shares after the&nbsp;<font color='red'>40%</font>&nbsp;selloff since August 28 stoked by SEC charges of securities fraud against Chairman and CEO Dr. Phillip Frost and others.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3388837-sec-charges-frost-honig-stock-promotion-schemes-opko-18-percent\" target=\"_blank\">SEC charges Frost and Honig with stock promotion schemes; OPKO down 18%</a> (Sept. 7)</li></ul><div class=\"tiny-share-widget\" data-id=\"3390816\" data-linked=\"Bargain hunters move into Opko Health, shares ahead 16%\" data-tweet=\"$OPK - Bargain hunters move into Opko Health, shares ahead 16% https://seekingalpha.com/news/3390816-bargain-hunters-move-opko-health-shares-ahead-16?source=tweet\" data-url=\"https://seekingalpha.com/news/3390816-bargain-hunters-move-opko-health-shares-ahead-16\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:34 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>52&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3390802\" data-ts=\"1537203960\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CATS\" target=\"_blank\">CATS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3390802-catasys-up-17\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Catasys up 17%</a></h4><ul><li>Thinly traded micro cap Catasys (<a href='https://seekingalpha.com/symbol/CATS' title='Catasys Inc.'>CATS</a> <font color='green'>+16.6%</font>), a developer of an analytics platform aimed at reducing the costs of behavioral healthcare, is up on a 10x surge in volume, albeit on turnover of only 377K shares. The stock has rallied&nbsp;<font color='green'>145%</font>&nbsp;since mid-May.</li><li>In mid-August, it <a href=\"https://www.sec.gov/Archives/edgar/data/1136174/000143774918015597/ex_121835.htm\" target=\"_blank\">reported </a>a 152% jump in Q2 billings to $5.2M. New member enrollment of 1,219 was up 289% from a year ago.</li><li>On the capital front, it recently secured up to $10M in debt financing. At the end of June, it had $5.6M in cash and equivalents while operations consumed $3.8M in H1.</li></ul><div class=\"tiny-share-widget\" data-id=\"3390802\" data-linked=\"Catasys up 17%\" data-tweet=\"$CATS - Catasys up 17% https://seekingalpha.com/news/3390802-catasys-up-17?source=tweet\" data-url=\"https://seekingalpha.com/news/3390802-catasys-up-17\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:06 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3390804\" data-ts=\"1537203708\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SIR\" target=\"_blank\">SIR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3390804-financials-top-5-gainers-losers-of-1-00-pm-09-17-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top 5 Gainers / Losers as of 1:00 PM (09/17/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/SIR' title='Select Income REIT'>SIR</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/OXBR' title='Oxbridge Re Holdings Limited'>OXBR</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/GGAL' title='Grupo Financiero Galicia S.A.'>GGAL</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/CWH' title='Camping World Holdings'>CWH</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/SUPV' title='Grupo Supervielle'>SUPV</a> <font color='green'>+7%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/GOV-OLD' title='Government Properties Income Trust'>GOV-OLD</a> <font color='red'>-21%</font>. <a href='https://seekingalpha.com/symbol/MHLD' title='Maiden Hldgs Ltd'>MHLD</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/CIFS' title='China Internet Nationwide Financial Services Inc.'>CIFS</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/RMR' title='The RMR Group Inc.'>RMR</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/GNW' title='Genworth Financial, Inc.'>GNW</a> <font color='red'>-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3390804\" data-linked=\"Financials - Top 5 Gainers / Losers as of 1:00 PM (09/17/2018)\" data-tweet=\"$SIR $SIR $OXBR - Financials - Top 5 Gainers / Losers as of 1:00 PM (09/17/2018) https://seekingalpha.com/news/3390804-financials-top-5-gainers-losers-of-1-00-pm-09-17-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3390804-financials-top-5-gainers-losers-of-1-00-pm-09-17-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:01 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3390798\" data-ts=\"1537203319\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OBSV\" target=\"_blank\">OBSV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3390798-obseva-up-13\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ObsEva up 13%</a></h4><ul><li>Thinly traded ObsEva (<a href='https://seekingalpha.com/symbol/OBSV' title='ObsEva'>OBSV</a> <font color='green'>+12.5%</font>) is up on more than double normal volume, albeit on turnover of only 312K shares. The stock in the reproductive health and pregnancy therapeutics developer has rallied&nbsp;<font color='green'>53%</font>&nbsp;since touching $10.79 on August 20.</li><li>On Friday, September 14, Barron's <a href=\"https://www.barrons.com/articles/obseva-a-small-biotech-with-a-promising-pipeline-1536938170\" target=\"_blank\">published </a>a bullish article citing a promising pipeline and allure as a takeover target.</li></ul><div class=\"tiny-share-widget\" data-id=\"3390798\" data-linked=\"ObsEva up 13%\" data-tweet=\"$OBSV - ObsEva up 13% https://seekingalpha.com/news/3390798-obseva-up-13?source=tweet\" data-url=\"https://seekingalpha.com/news/3390798-obseva-up-13\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:55 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3390795\" data-ts=\"1537202854\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NEWA\" target=\"_blank\">NEWA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3390795-newater-technology-down-4-post-h1-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Newater Technology down 4% post H1 results</a></h4><ul><li>Newater Technology (<a href='https://seekingalpha.com/symbol/NEWA' title='Newater Technology, Inc.'>NEWA</a> <font color='red'>-4.4%</font>) reported H1 revenue growth of 267.5% Y/Y to $26.48M, increase was partially driven by the increase in both the number and size of the projects.</li><li>H1 Gross margin&nbsp;<font color='green'>improved by 2,487 bps</font>&nbsp;to 51.5%; and operating margin&nbsp;<font color='green'>improved by 3,191 bps</font>&nbsp;to 33.8%.</li><li>The increase in operating income and operating margin mainly resulted from the increase of revenues derived from a large customer. The gross margin of wastewater treatment services for six months ended June 30, 2018 was 60.26%.</li><li>SG&amp;A expenses increased 162.9% Y/Y to $4.69M.</li><li>Net cash provided by operating activities was $4.86M, compared to $1.17M a year ago.</li><li>Company has total cash, cash equivalents, and restricted cash of $14.48M as of June 30, 2018, compare to $2.13M a year ago.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3390775-newater-technology-reports-1h-results\" target=\"_blank\">Newater Technology reports 1H results</a> (Sept. 17)</li></ul><div class=\"tiny-share-widget\" data-id=\"3390795\" data-linked=\"Newater Technology down 4% post H1 results\" data-tweet=\"$NEWA - Newater Technology down 4% post H1 results https://seekingalpha.com/news/3390795-newater-technology-down-4-post-h1-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3390795-newater-technology-down-4-post-h1-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:47 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3390797\" data-ts=\"1537202721\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/QCOM\" target=\"_blank\">QCOM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3390797-apple-itc-staff-urging-finding-of-no-violation-of-qualcomm-patents\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Apple: ITC staff urging finding of no violation of Qualcomm patents</a></h4><ul>   <li>Apple (<a href=\"http://seekingalpha.com/symbol/AAPL\" target=\"_blank\">AAPL</a> <font color='red'>-1.7%</font>) says that International Trade Commission staffers are recommending a finding of no violation of three Qualcomm (NASDAQ:<a href='https://seekingalpha.com/symbol/QCOM' title='Qualcomm Inc.'>QCOM</a>) patents in the two companies' long-running dispute, Bloomberg reports.</li>    <li>That came up in opening arguments from Apple counsel William Lee, according to the report.</li>    <li>After a leg lower, <a href='https://seekingalpha.com/symbol/QCOM' title='Qualcomm Inc.'>QCOM</a> is <font color='red'>down 1.3%</font> today.</li>    <li>In July, a large lobbying group (of which Apple isn't a member) <a href=\"https://seekingalpha.com/news/3280290-tech-lobbying-group-backs-apple-qualcomm-dispute\" target=\"_blank\">filed comments</a> supporting Apple's side of the issue. Qualcomm has pressed to <a href=\"https://seekingalpha.com/news/3277356-qualcomm-wants-court-block-iphone-imports-sales\" target=\"_blank\">block iPhone imports and sales</a> due to alleged infringements.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3390797\" data-linked=\"Apple: ITC staff urging finding of no violation of Qualcomm patents\" data-tweet=\"$QCOM $QCOM $AAPL - Apple: ITC staff urging finding of no violation of Qualcomm patents https://seekingalpha.com/news/3390797-apple-itc-staff-urging-finding-of-no-violation-of-qualcomm-patents?source=tweet\" data-url=\"https://seekingalpha.com/news/3390797-apple-itc-staff-urging-finding-of-no-violation-of-qualcomm-patents\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:45 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>58&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3390796\" data-ts=\"1537202702\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SNMX\" target=\"_blank\">SNMX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3390796-midday-gainers-losers-09-17-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers (09/17/2018)</a></h4><ul>     <li><strong>Gainers:</strong> <a href='https://seekingalpha.com/symbol/SNMX' title='Senomyx, Inc.'>SNMX</a> <font color='green'>+40%</font>. <a href='https://seekingalpha.com/symbol/AWSM' title='Cool Holdings Inc.'>AWSM</a> <font color='green'>+35%</font>. <a href='https://seekingalpha.com/symbol/MYND' title='MYnd Analytics, Inc.'>MYND</a> <font color='green'>+25%</font>. <a href='https://seekingalpha.com/symbol/QTM-OLD' title='Quantum Corporation'>QTM-OLD</a> <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/OPK' title='OPKO Health, Inc.'>OPK</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/LWAY' title='Lifeway Foods, Inc.'>LWAY</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/CATS' title='Catasys Inc.'>CATS</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/NEPT' title='Neptune Wellness Solutions Inc.'>NEPT</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/ADIL' title='ADial Pharmaceuticals, Inc'>ADIL</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/VTNR' title='Vertex Energy, Inc.'>VTNR</a> <font color='green'>+15%</font>.</li>      <li><strong>Losers:</strong> <a href='https://seekingalpha.com/symbol/RDCM' title='Radcom Ltd.'>RDCM</a> <font color='red'>-30%</font>. <a href='https://seekingalpha.com/symbol/QTT' title='Qutoutiao'>QTT</a> <font color='red'>-28%</font>. <a href='https://seekingalpha.com/symbol/HMNY' title='Helios and Matheson Analytics, Inc.'>HMNY</a> <font color='red'>-25%</font>. <a href='https://seekingalpha.com/symbol/MRSN' title='Mersana Therapeutics'>MRSN</a> <font color='red'>-24%</font>. <a href='https://seekingalpha.com/symbol/GOV-OLD' title='Government Properties Income Trust'>GOV-OLD</a> <font color='red'>-21%</font>. <a href='https://seekingalpha.com/symbol/ATXI' title='Avenue Therapeutics'>ATXI</a> <font color='red'>-18%</font>. <a href='https://seekingalpha.com/symbol/TNDM' title='Tandem Diabetes Care, Inc.'>TNDM</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/LINK' title='Interlink Electronics'>LINK</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/KLXI' title='KLX Inc.'>KLXI</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/MYSZ' title='MySize Inc.'>MYSZ</a> <font color='red'>-12%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3390796\" data-linked=\"Midday Gainers / Losers (09/17/2018)\" data-tweet=\"$SNMX $SNMX $AWSM - Midday Gainers / Losers (09/17/2018) https://seekingalpha.com/news/3390796-midday-gainers-losers-09-17-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3390796-midday-gainers-losers-09-17-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:45 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3390791\" data-ts=\"1537201435\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DIS\" target=\"_blank\">DIS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3390791-wsj-hulu-may-make-sense-in-comcast-hands\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">WSJ: Hulu may make more sense in Comcast hands</a></h4><ul>   <li>As Disney (NYSE:<a href='https://seekingalpha.com/symbol/DIS' title='The Walt Disney Company'>DIS</a>) prepares to take pole position in the shared leadership at Hulu, a <i>WSJ</i> take suggests the streamer may make more sense <a href=\"https://www.wsj.com/articles/disney-doesnt-need-hulu-to-challenge-netflix-1537178580\" target=\"_blank\">in the hands of co-owner Comcast</a> (<a href=\"http://seekingalpha.com/symbol/CMCSA\" target=\"_blank\">CMCSA</a> <font color='green'>+0.4%</font>).</li>    <li>Disney's media-asset transaction with Fox (<a href='https://seekingalpha.com/symbol/FOX' title='Twenty-First Century Fox, Inc.'>FOX</a> <font color='red'>-0.2%</font>, <a href='https://seekingalpha.com/symbol/FOXA' title='Twenty-First Century Fox, Inc.'>FOXA</a> <font color='red'>-0.2%</font>) will get it Fox's 30% of Hulu, which combined with Disney's own 30% would make $60%. That would leave Comcast with 30% and WarnerMedia (<a href=\"http://seekingalpha.com/symbol/T\" target=\"_blank\">T</a> <font color='red'>-0.2%</font>) with 10% via AT&amp;T's takeover of Time Warner's share.</li>    <li>But Disney might be better off fighting Netflix (<a href=\"http://seekingalpha.com/symbol/NFLX\" target=\"_blank\">NFLX</a> <font color='red'>-2.2%</font>) without Hulu, Elizabeth Winkler notes. For one thing, it's launching more branded streaming services to draw off its classic library along with Fox's. And it's hard to imagine Disney catching up to Netflix if it divides its attention among three platforms.</li>    <li>Buying out Comcast's Hulu stake may be unlikely with an unwilling seller, and pouring its energy into Hulu entirely would give a boost to Comcast and AT&amp;T -- so Comcast (which needs Hulu more than Disney does) could be the candidate to take the stake off Disney's hands, Winkler suggests.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3390791\" data-linked=\"WSJ: Hulu may make more sense in Comcast hands\" data-tweet=\"$DIS $DIS $FOX - WSJ: Hulu may make more sense in Comcast hands https://seekingalpha.com/news/3390791-wsj-hulu-may-make-sense-in-comcast-hands?source=tweet\" data-url=\"https://seekingalpha.com/news/3390791-wsj-hulu-may-make-sense-in-comcast-hands\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:23 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>57&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3390782\" data-ts=\"1537200035\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NBEV\" target=\"_blank\">NBEV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3390782-consumer-top-5-gainers-losers-of-12-00-pm-09-17-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer - Top 5 Gainers / Losers as of 12:00 PM (09/17/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/NBEV' title='New Age Beverages Corporation'>NBEV</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/TIS' title='Orchids Paper Products Company'>TIS</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/DFBG-OLD' title='Differential Brands Group Inc.'>DFBG-OLD</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/BRFS' title='BRF-Brasil Foods S.A.'>BRFS</a> <font color='green'>+7%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/NIO' title='NIO'>NIO</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/WKHS' title='Workhorse Group Inc.'>WKHS</a> <font color='red'>-5%</font>. <a href='https://seekingalpha.com/symbol/SONO' title='Sonos, Inc.'>SONO</a> <font color='red'>-5%</font>. <a href='https://seekingalpha.com/symbol/NTZ' title='Natuzzi S.p.A.'>NTZ</a> <font color='red'>-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3390782\" data-linked=\"Consumer - Top 5 Gainers / Losers as of 12:00 PM (09/17/2018)\" data-tweet=\"$NBEV $NBEV $TIS - Consumer - Top 5 Gainers / Losers as of 12:00 PM (09/17/2018) https://seekingalpha.com/news/3390782-consumer-top-5-gainers-losers-of-12-00-pm-09-17-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3390782-consumer-top-5-gainers-losers-of-12-00-pm-09-17-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3390781\" data-ts=\"1537199836\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IP\" target=\"_blank\">IP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3390781-packaging-stocks-track-higher-on-solid-data-read\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Packaging stocks track higher on solid data read</a></h4><ul> <li>Wall Street analysts says packaging industry data for August came in ahead estimates in a positive sign for the sector, per Bloomberg.</li> <li>Containerboard demand is being closely watched to see if the pace will match up with the supply growth that's upcoming.</li> <li>Sector watch: International Paper (<a href='https://seekingalpha.com/symbol/IP' title='International Paper Co.'>IP</a> <font color='green'>+1.4%</font>), Packaging Corporation of America (<a href='https://seekingalpha.com/symbol/PKG' title='Packaging Corporation Of America'>PKG</a> <font color='green'>+1.1%</font>), WestRock (<a href='https://seekingalpha.com/symbol/WRK' title='WestRock Company'>WRK</a> <font color='green'>+1.3%</font>), Graphic Packaging (<a href='https://seekingalpha.com/symbol/GPK' title='Graphic Packaging Holding Company'>GPK</a> <font color='green'>+0.1%</font>), KapStone Paper (<a href='https://seekingalpha.com/symbol/KS' title='KapStone Paper and Packaging Corporation'>KS</a> <font color='green'>+0.2%</font>) and&nbsp; Domtar UFS.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3390781\" data-linked=\"Packaging stocks track higher on solid data read\" data-tweet=\"$IP $IP $PKG - Packaging stocks track higher on solid data read https://seekingalpha.com/news/3390781-packaging-stocks-track-higher-on-solid-data-read?source=tweet\" data-url=\"https://seekingalpha.com/news/3390781-packaging-stocks-track-higher-on-solid-data-read\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:57 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3390773\" data-ts=\"1537198360\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/USAK\" target=\"_blank\">USAK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3390773-trucking-stocks-in-reverse\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Trucking stocks in reverse</a></h4><ul> <li>The trucking and logistics sectors are weak on the day, led by declines in USA Truck (<a href='https://seekingalpha.com/symbol/USAK' title='USA Truck, Inc.'>USAK</a> <font color='red'>-3.3%</font>), Old Dominion Freight Lines (<a href='https://seekingalpha.com/symbol/ODFL' title='Old Dominion Freight Line, Inc.'>ODFL</a> <font color='red'>-2%</font>), Werner Enterprises (<a href='https://seekingalpha.com/symbol/WERN' title='Werner Enterprises, Inc.'>WERN</a> <font color='red'>-3.4%</font>), Heartland Express (<a href='https://seekingalpha.com/symbol/HTLD' title='Heartland Express, Inc.'>HTLD</a> <font color='red'>-2.6%</font>), Landstar Systemes (<a href='https://seekingalpha.com/symbol/LSTR' title='Landstar System, Inc.'>LSTR</a> <font color='red'>-1.7%</font>), Echo Global Logistics (<a href='https://seekingalpha.com/symbol/ECHO' title='Echo Global Logistics, Inc.'>ECHO</a> <font color='red'>-2.3%</font>), Schneider National (<a href='https://seekingalpha.com/symbol/SNDR' title='Schneider National'>SNDR</a> <font color='red'>-2.1%</font>), Ryder (<a href='https://seekingalpha.com/symbol/R' title='Ryder System, Inc.'>R</a> <font color='red'>-2.7%</font>), Hub Group (<a href='https://seekingalpha.com/symbol/HUBG' title='Hub Group, Inc.'>HUBG</a> <font color='red'>-2.2%</font>), and C.H. Robinson Worldwide (<a href='https://seekingalpha.com/symbol/CHRW' title='C.H. Robinson Worldwide Inc.'>CHRW</a> <font color='red'>-2.4%</font>).</li> <li>Traders with a technical analysts bent are pointing to breaks below the group's 50-day and 200-day daily moving average as key events.</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3390773\" data-linked=\"Trucking stocks in reverse\" data-tweet=\"$USAK $USAK $ODFL - Trucking stocks in reverse https://seekingalpha.com/news/3390773-trucking-stocks-in-reverse?source=tweet\" data-url=\"https://seekingalpha.com/news/3390773-trucking-stocks-in-reverse\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:32 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3390765\" data-ts=\"1537198033\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UMRX\" target=\"_blank\">UMRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3390765-unum-therapeutics-actr707-shows-encouraging-action-in-blood-cancer-study-shares-up-2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Unum Therapeutics&#39; ACTR707 shows encouraging action in blood cancer study; shares up 2%</a></h4><ul><li>Unum Therapeutics (<a href='https://seekingalpha.com/symbol/UMRX' title='Unum Therapeutics Inc.'>UMRX</a> <font color='green'>+2.4%</font>) is up on light volume on the heels of its <a href=\"https://seekingalpha.com/pr/17271122-unum-therapeutics-announces-abstract-accepted-presentation-fourth-cri-cimt-eati-aacr\" target=\"_blank\">announcement </a>of positive preliminary data from its <a href=\"https://clinicaltrials.gov/ct2/show/NCT03189836?lead=unum+therapeutics&amp;rank=2\" target=\"_blank\">ATTCK-20-03</a> clinical trial evaluating ACTR707, combined with Roche's Rituxan (rituximab), in patients with relapsed/refractory CD20-positive B cell non-Hodgkin lymphoma &#40;NHL&#41;. The results were presented at the CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference on September 30 in New York City.</li><li>Half of the patients (n=3/6) receiving the first dose level (40M ACTR+ T cells) achieved complete responses. No dose-limiting toxicities (DLTs) were observed in any of the four DLT-evaluable patients.</li><li>CEO Chuck Wilson says, &ldquo;These preliminary clinical data suggest&nbsp;that&nbsp;complete responses&nbsp;may be achieved without cytokine release syndrome, further validating the potential of our proprietary ACTR technology platform. The ATTCK-20-03 trial is a key element of our strategy to develop novel therapeutics for patients with no available treatment options.&rdquo;</li><li>Enrollment in the second dose cohort (60M ACTR+ T cells) has been completed. Updated data will be presented later this year (most likely at ASH in December).</li><li>The company says <a href=\"https://www.unumrx.com/pipeline\" target=\"_blank\">ACTR707</a> is an Antibody-Coupled T cell Receptor &#40;ACTR&#41; construct made from the patient's own T cells, harvested from the blood via leukapheresis, engineered to incorporate the ACTR transgene, expanded, then infused back into the patient where it mobilzes (with the biologic drug) a cytotoxic cellular response to attack antibody-labeled cancer cells.</li></ul><div class=\"tiny-share-widget\" data-id=\"3390765\" data-linked=\"Unum Therapeutics&#39; ACTR707 shows encouraging action in blood cancer study; shares up 2%\" data-tweet=\"$UMRX - Unum Therapeutics&#39; ACTR707 shows encouraging action in blood cancer study; shares up 2% https://seekingalpha.com/news/3390765-unum-therapeutics-actr707-shows-encouraging-action-in-blood-cancer-study-shares-up-2?source=tweet\" data-url=\"https://seekingalpha.com/news/3390765-unum-therapeutics-actr707-shows-encouraging-action-in-blood-cancer-study-shares-up-2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:27 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3390771\" data-ts=\"1537197717\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SPA\" target=\"_blank\">SPA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3390771-sparton-higher-on-m-report\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sparton higher on M&amp;A report</a></h4><ul> <li>Sparton (NYSE:<a href='https://seekingalpha.com/symbol/SPA' title='Sparton Corporation'>SPA</a>) is&nbsp;<font color='green'>up 4.9%</font>&nbsp;after DealReporter reported late on Friday that the company is being looked at by L3 Technologies (<a href='https://seekingalpha.com/symbol/LLL' title='L3 Technologies'>LLL</a> <font color='green'>+0.5%</font>) for a possible acquisition.</li> <li>LLL is in the mix after Lockheed Martin took a pass on bidding for Sparton after engaging in talks.</li> <li>Sparton trades at its highest level in more than six weeks, hitting $14.64 earlier in the session.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3390771\" data-linked=\"Sparton higher on M&amp;A report\" data-tweet=\"$SPA $SPA $LLL - Sparton higher on M&amp;A report https://seekingalpha.com/news/3390771-sparton-higher-on-m-report?source=tweet\" data-url=\"https://seekingalpha.com/news/3390771-sparton-higher-on-m-report\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:21 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3390768\" data-ts=\"1537196986\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FTR\" target=\"_blank\">FTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3390768-frontier-communications-resumes-operations-in-south-carolina\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Frontier Communications resumes operations in South Carolina</a></h4><ul>     <li>Frontier Communications (<a href='https://seekingalpha.com/symbol/FTR' title='Frontier Communications Corporation'>FTR</a> <font color='green'>+6.9%</font>) has resumed full operations in its service areas in South Carolina. Repair and installation technicians, contact center employees and others will return to work.</li><li>Frontier&rsquo;s operations in North Carolina continue uninterrupted.</li><li><a href=\"https://seekingalpha.com/pr/17271322-frontier-communications-resumes-operations-south-carolina-north-carolina-operations-continue\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3390768\" data-linked=\"Frontier Communications resumes operations in South Carolina\" data-tweet=\"$FTR - Frontier Communications resumes operations in South Carolina https://seekingalpha.com/news/3390768-frontier-communications-resumes-operations-in-south-carolina?source=tweet\" data-url=\"https://seekingalpha.com/news/3390768-frontier-communications-resumes-operations-in-south-carolina\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:09 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3390767\" data-ts=\"1537196912\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TI\" target=\"_blank\">TI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3390767-telecom-italia-higher-amid-succession-speculation\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Telecom Italia higher amid succession speculation</a></h4><ul>   <li>Telecom Italia (NYSE:<a href='https://seekingalpha.com/symbol/TI' title='Telecom Italia S.P.A.'>TI</a>) is <font color='green'>up 5.5%</font> in U.S. trading and was halted in Milan, limit up.</li>    <li>Chatter is pointing to a reason for the jump: a paywalled article in <a href=\"https://www.milanofinanza.it/news/telecom-se-c-e-altavilla-in-linea-201809142215381883\" target=\"_blank\">Milano Finanza</a> that suggests shareholders could push for boardmember Alfredo Altavilla to succeed current CEO Amos Genish.</li>    <li>Altavilla was a close aide to Fiat Chrysler CEO Sergio Marchionne, and resigned as the company's European chief after being passed over to become the new CEO following Marchionne's illness this summer. Marchionne died in July the week after relinquishing the top spot.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3390767\" data-linked=\"Telecom Italia higher amid succession speculation\" data-tweet=\"$TI - Telecom Italia higher amid succession speculation https://seekingalpha.com/news/3390767-telecom-italia-higher-amid-succession-speculation?source=tweet\" data-url=\"https://seekingalpha.com/news/3390767-telecom-italia-higher-amid-succession-speculation\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:08 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3390759\" data-ts=\"1537196431\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MYND\" target=\"_blank\">MYND</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3390759-healthcare-top-5-gainers-losers-of-11-00-09-17-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers as of 11:00 AM (09/17/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/MYND' title='MYnd Analytics, Inc.'>MYND</a> <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/OASM' title='Oasmia Pharmaceutical'>OASM</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/CATS' title='Catasys Inc.'>CATS</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/OBSV' title='ObsEva'>OBSV</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/XTLB' title='XTL Biopharmaceuticals Ltd.'>XTLB</a> <font color='green'>+9%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/ECOR' title='ElectroCore'>ECOR</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/TNDM' title='Tandem Diabetes Care, Inc.'>TNDM</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/MRSN' title='Mersana Therapeutics'>MRSN</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/KRYS' title='Krystal Biotech'>KRYS</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/MCRB' title='Seres Therapeutics'>MCRB</a> <font color='red'>-9%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3390759\" data-linked=\"Healthcare - Top 5 Gainers / Losers as of 11:00 AM (09/17/2018)\" data-tweet=\"$MYND $EMMA $OASM - Healthcare - Top 5 Gainers / Losers as of 11:00 AM (09/17/2018) https://seekingalpha.com/news/3390759-healthcare-top-5-gainers-losers-of-11-00-09-17-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3390759-healthcare-top-5-gainers-losers-of-11-00-09-17-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:00 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3390746\" data-ts=\"1537195047\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ORHOF\" target=\"_blank\">ORHOF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3390746-cannaroyalty-to-sell-equity-stake-in-wagner-dimas\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CannaRoyalty to sell equity stake in Wagner Dimas</a></h4><ul>     <li>CannaRoyalty (CNNRF <font color='green'>+4.3%</font>) to sell 22% equity stake in Wagner Dimas to Australis Cannabis for a consideration of C$3.0M.</li>     <li>The sale of CannaRoyalty&rsquo;s equity interest in Wagner Dimas represents an ~182% return on investment for CannaRoyalty&rsquo;s shareholders.</li>     <li>Agreement advances CannaRoyalty&rsquo;s stated commitment to create shareholder value by realizing gains on non-core assets.</li><li><a href=\"http://cannaroyalty.com/cannaroyalty-to-sell-equity-stake-in-wagner-dimas-to-australis-cannabis/\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3390746\" data-linked=\"CannaRoyalty to sell equity stake in Wagner Dimas\" data-tweet=\"$ORHOF - CannaRoyalty to sell equity stake in Wagner Dimas https://seekingalpha.com/news/3390746-cannaroyalty-to-sell-equity-stake-in-wagner-dimas?source=tweet\" data-url=\"https://seekingalpha.com/news/3390746-cannaroyalty-to-sell-equity-stake-in-wagner-dimas\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:37 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3390747\" data-ts=\"1537195047\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PBR\" target=\"_blank\">PBR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3390747-petrobras-aims-to-boost-production-in-2019-cut-debt-10b\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Petrobras aims to boost production in 2019, cut debt by $10B</a></h4><ul>     <li>Petrobras (<a href='https://seekingalpha.com/symbol/PBR' title='Petrobras - Petroleo Brasileiro S.A.'>PBR</a> <font color='green'>+1.9%</font>) plans to raise production by as much as 10% to ~2.3M bbl/day next year and <a href=\"https://uk.reuters.com/article/uk-brazil-petrobras-cfo/petrobras-to-boost-oil-output-in-2019-cut-debt-10-billion-cfo-idUKKCN1LX18P\" target=\"_blank\">cut net debt by $10B</a>, CFO Rafael Grisolia says.</li>     <li>PBR - the world&rsquo;s most indebted oil company - is on course to reduce debt to $69B by year-end 2018 from $106B in 2014, despite falling short of its $21B asset sales target, Grisolia tells Reuters in an interview.</li>     <li>A&nbsp;$10B reduction in net debt would reach  a ratio of 2x net debt-to-EBITDA, the CFO says, and the company aims to continue cutting debt until the ratio hits 1x-1.5x, which would put the company in line with global oil majors.</li><li>Over the next 5-6 years upon achieving debt restructuring  targets, PBR may consider foreign investments to facilitate  exports of rising production from the development of Brazil's deepwater  pre-salt fields, Grisolia says.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3390747\" data-linked=\"Petrobras aims to boost production in 2019, cut debt by $10B\" data-tweet=\"$PBR - Petrobras aims to boost production in 2019, cut debt by $10B https://seekingalpha.com/news/3390747-petrobras-aims-to-boost-production-in-2019-cut-debt-10b?source=tweet\" data-url=\"https://seekingalpha.com/news/3390747-petrobras-aims-to-boost-production-in-2019-cut-debt-10b\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:37 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3390745\" data-ts=\"1537194938\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MU\" target=\"_blank\">MU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3390745-bmo-cuts-microns-price-target-on-dram-pricing\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BMO cuts Micron&#39;s price target on DRAM pricing</a></h4><ul><li>        BMO Capital Markets<a href=\"https://www.cnbc.com/2018/09/17/two-top-brokerages-cut-micron-target-by-25percent-ahead-of-earnings.html\" target=\"_blank\"> reiterates</a> a Market Perform rating on Micron (NASDAQ:<a href='https://seekingalpha.com/symbol/MU' title='Micron Technology Inc.'>MU</a>) but cuts the price target to $45, a 1.5% upside.</li><li>               Analyst Ambrish Srivastava: &ldquo;While the investment community has been in general wary about NAND pricing for some time, it is the weakness in DRAM pricing, which we believe has caught investors by surprise. We believe downward estimate revisions for Micron are just beginning. Our estimates remain below those of consensus.&rdquo;&nbsp;</li><li>               Micron shares are<font color='red'> down 1.9%</font>&nbsp;to $43.46.&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3390654-deutsche-bank-lowers-microns-target-ahead-earnings\" target=\"_blank\">Deutsche Bank lowers Micron's target ahead of earnings</a> (Sept. 17)</li></ul><div class=\"tiny-share-widget\" data-id=\"3390745\" data-linked=\"BMO cuts Micron&#39;s price target on DRAM pricing\" data-tweet=\"$MU - BMO cuts Micron&#39;s price target on DRAM pricing https://seekingalpha.com/news/3390745-bmo-cuts-microns-price-target-on-dram-pricing?source=tweet\" data-url=\"https://seekingalpha.com/news/3390745-bmo-cuts-microns-price-target-on-dram-pricing\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:35 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>141&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3390743\" data-ts=\"1537194824\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BUKS\" target=\"_blank\">BUKS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3390743-on-butler-nationals-q1-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Butler National&#39;s Q1 results</a></h4><ul><li>Butler National (<a href='https://seekingalpha.com/symbol/BUKS' title='Butler National Corp.'>OTCQB:BUKS</a>) reported Q1 revenue growth of 15% Y/Y to $13.4M.</li><li>Segment revenue: Professional services $7.95M (+7% Y/Y) and Aerospace products $5.45M (+30% Y/Y).</li><li>Q1 Operating margin<font color='green'> improved by 118 bps</font>&nbsp;to 6.7%. Segment operating margins: Professional services 7%&nbsp;<font color='green'>up by 210 bps</font>&nbsp;and Aerospace products&nbsp;<font color='red'>declined by 50 bps</font>&nbsp;to 6.5%.</li><li>G&amp;A expenses increased by 27.8% Y/Y to $1.69M.</li><li>Total inventories increased by 5.5% Y/Y to $7.51M.</li><li>Net cash provided by operating activities was $1.54M, compared to $932k a year ago.</li><li>Company has cash balance of $7.54M as of July 31, 2018.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3390710-butler-national-reports-q1-results\" target=\"_blank\">Butler National reports Q1 results</a> (Sept. 17)</li></ul><div class=\"tiny-share-widget\" data-id=\"3390743\" data-linked=\"More on Butler National&#39;s Q1 results\" data-tweet=\"$BUKS - More on Butler National&#39;s Q1 results https://seekingalpha.com/news/3390743-on-butler-nationals-q1-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3390743-on-butler-nationals-q1-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:33 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3390739\" data-ts=\"1537194176\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/COTY\" target=\"_blank\">COTY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3390739-coty-higher-jab-factor-still-in-background\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Coty higher with JAB factor still in the background</a></h4><ul> <li>Coty (<a href='https://seekingalpha.com/symbol/COTY' title='Coty Inc.'>COTY</a> <font color='green'>+2.9%</font>) trades higher after Stifel points to a potential share price catalyst in the form of JAB Holdings increasing its stake.</li> <li>JAB Holdings has been reported before to be interested in acquiring full control of Coty at some point.</li> <li>Sources: Financial Times, Bloomberg</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3390739\" data-linked=\"Coty higher with JAB factor still in the background\" data-tweet=\"$COTY - Coty higher with JAB factor still in the background https://seekingalpha.com/news/3390739-coty-higher-jab-factor-still-in-background?source=tweet\" data-url=\"https://seekingalpha.com/news/3390739-coty-higher-jab-factor-still-in-background\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:22 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3390732\" data-ts=\"1537193726\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CRSP\" target=\"_blank\">CRSP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3390732-crsp-therapeutics-teams-up-viacyte-in-diabetes-investors-unmoved-shares-down-5\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CRSP Therapeutics teams up with ViaCyte in diabetes; investors unmoved, shares down 5%</a></h4><ul><li>CRISPR Therapeutics (<a href='https://seekingalpha.com/symbol/CRSP' title='CRISPR Therapeutics'>CRSP</a> <font color='red'>-4.7%</font>) has agreed to <a href=\"https://seekingalpha.com/pr/17271255-crispr-therapeutics-viacyte-announce-strategic-collaboration-develop-gene-edited-stem-cell\" target=\"_blank\">collaborate </a>with privately held ViaCyte to develop and commercialize gene-edited allogeneic stem cell therapies to treat diabetes. The partnership will leverage ViaCyte's know-how in generating pancreatic-lineage cells from stem cells and delivering them to patients with CRISPR's expertise in gene editing.</li><li>Under the terms of the agreement, CRSP will pay ViaCyte $15M upfront in cash or stock. ViaCyte has the option, under certain circumstances, to receive an additional $10M from CRSP in convertible debt. The companies will jointly explore the development of an immune-evasive stem cell line as a first step. Once a product candidate has been identified, they will jointly develop and commercialize.</li><li>The selling pressure may be due to the absence of an update on the FDA clinical hold on CTX001 in sickle cell disease, in place since May.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3360517-crispr-therapeutics-20-percent-hours-ind-hold-sickle-cell-candidate-ctx001\" target=\"_blank\">CRISPR Therapeutics down 20% after hours on IND hold for sickle cell candidate CTX001</a> (May 30)</li><li>CRISPR/Cas9 compatriots Editas Medicine (<a href='https://seekingalpha.com/symbol/EDIT' title='Editas Medicine'>EDIT</a> <font color='red'>-2.2%</font>) and Intellia Therapeutics (<a href='https://seekingalpha.com/symbol/NTLA' title='Intellia Therapeutics'>NTLA</a> <font color='red'>-3.5%</font>) are in the red as well.</li></ul><div class=\"tiny-share-widget\" data-id=\"3390732\" data-linked=\"CRSP Therapeutics teams up with ViaCyte in diabetes; investors unmoved, shares down 5%\" data-tweet=\"$CRSP $CRSP $EDIT - CRSP Therapeutics teams up with ViaCyte in diabetes; investors unmoved, shares down 5% https://seekingalpha.com/news/3390732-crsp-therapeutics-teams-up-viacyte-in-diabetes-investors-unmoved-shares-down-5?source=tweet\" data-url=\"https://seekingalpha.com/news/3390732-crsp-therapeutics-teams-up-viacyte-in-diabetes-investors-unmoved-shares-down-5\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:15 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3390729\" data-ts=\"1537192930\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GPIC\" target=\"_blank\">GPIC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3390729-gaming-partners-runs-to-five-month-high\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gaming Partners runs to five-month high</a></h4><ul> <li>Gaming Partners International (NASDAQ:<a href='https://seekingalpha.com/symbol/GPIC' title='Gaming Partners International Corporation'>GPIC</a>) is <font color='green'>up 7.8%</font> in early trading ahead of the company's earnings report due out at the end of the week.</li> <li>Shares of GPIC traded as high as $9.86 earlier in the day to reach their highest level since April.</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3390729\" data-linked=\"Gaming Partners runs to five-month high\" data-tweet=\"$GPIC - Gaming Partners runs to five-month high https://seekingalpha.com/news/3390729-gaming-partners-runs-to-five-month-high?source=tweet\" data-url=\"https://seekingalpha.com/news/3390729-gaming-partners-runs-to-five-month-high\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:02 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3390712\" data-ts=\"1537191513\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GPRO\" target=\"_blank\">GPRO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3390712-oppenheimer-conservative-on-gopro\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oppenheimer conservative on GoPro</a></h4><ul> <li>Oppenheimer says conditions couldn't be better for GoPro (<a href='https://seekingalpha.com/symbol/GPRO' title='GoPro'>GPRO</a> <font color='green'>+3.1%</font>) as it heads into the holiday period with a clean inventory position, although consumers will be the final judge on how well the products fly off the shelves.</li> <li>Oppenheimer take: \"We adjust our 2019 estimates up slightly but they remain conservative. Maintain Perform until we get more confidence in consumer demand.\"</li> <li>Shares of GoPro are down 15.5% YTD.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3390712\" data-linked=\"Oppenheimer conservative on GoPro\" data-tweet=\"$GPRO - Oppenheimer conservative on GoPro https://seekingalpha.com/news/3390712-oppenheimer-conservative-on-gopro?source=tweet\" data-url=\"https://seekingalpha.com/news/3390712-oppenheimer-conservative-on-gopro\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:38 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3390707\" data-ts=\"1537191025\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NIO\" target=\"_blank\">NIO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3390707-niominus-5-in-early-trading\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NIO -5% in early trading</a></h4><ul> <li>NIO (NYSE:<a href='https://seekingalpha.com/symbol/NIO' title='NIO'>NIO</a>) is <font color='red'>down 5.13%</font> in premarket trading.</li> <li>A bolt arrived in the luxury EV sector this morning when the Saudi wealth fund invested $1B in Lucid Motors as part of a new funding deal.</li> <li>Previously: <a href=\"https://seekingalpha.com/news/3390700-tesla-drops-lucid-moment\" target=\"_blank\">Tesla drops after Lucid moment</a> (Sept. 17)</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3390707\" data-linked=\"NIO -5% in early trading\" data-tweet=\"$NIO - NIO -5% in early trading https://seekingalpha.com/news/3390707-niominus-5-in-early-trading?source=tweet\" data-url=\"https://seekingalpha.com/news/3390707-niominus-5-in-early-trading\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:30 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3390703\" data-ts=\"1537190818\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MYND\" target=\"_blank\">MYND</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3390703-mynd-analytics-up-43-premarket-on-fda-accelerated-review-status-for-peer-4_0\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MYnd Analytics up 43% premarket on FDA accelerated review status for PEER 4.0</a></h4><ul><li>Nano cap MYnd Analytics (NASDAQ:<a href='https://seekingalpha.com/symbol/MYND' title='MYnd Analytics, Inc.'>MYND</a>) is up&nbsp;<font color='green'>43%</font>&nbsp;premarket on increased volume on the heels of its <a href=\"https://seekingalpha.com/pr/17271452-fda-designates-breakthrough-device-status-mynd-analytics-peer-4_0\" target=\"_blank\">announcement </a>that the FDA has granted Breakthrough Device status for its fourth-generation PEER phenotype database, used to predict how a patient will respond to a specific drug.</li><li>The tag provides for accelerated review of its marketing application.</li></ul><div class=\"tiny-share-widget\" data-id=\"3390703\" data-linked=\"MYnd Analytics up 43% premarket on FDA accelerated review status for PEER 4.0\" data-tweet=\"$MYND $EMMA - MYnd Analytics up 43% premarket on FDA accelerated review status for PEER 4.0 https://seekingalpha.com/news/3390703-mynd-analytics-up-43-premarket-on-fda-accelerated-review-status-for-peer-4_0?source=tweet\" data-url=\"https://seekingalpha.com/news/3390703-mynd-analytics-up-43-premarket-on-fda-accelerated-review-status-for-peer-4_0\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:26 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3390700\" data-ts=\"1537190740\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VWAGY\" target=\"_blank\">VWAGY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3390700-tesla-drops-after-lucid-moment\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tesla drops after Lucid moment</a></h4><ul> <li>There's some interesting news in the global EV sector to digest.</li><li>The Saudi Public Investment Fund <a href=\"https://seekingalpha.com/pr/17271491-lucid-motors-executes-us-1bn-investment-agreement-public-investment-fund-saudi-arabia\" target=\"_blank\">signed</a> an agreement with <a href=\"https://lucidmotors.com/\" target=\"_blank\">Lucid Motors</a> to invest over $1B to help fund the electric vehicle maker's planned launch of its Lucid Air model in 2020.</li> <li>Lucid plans to use the funding to complete engineering development and testing of the Lucid Air, as well as construct its factory in Casa Grande, Arizona.</li> <li>EV partnership details: \"Lucid and PIF are strongly aligned around the vision to create a global luxury electric car company based in the heart of Silicon Valley with world-class engineering talent.  Lucid will work closely with PIF to ensure a strategic focus on quickly bringing its products to market at a time of rapid change in the automotive industry. By investing in the rapidly expanding electric vehicle market, PIF is gaining exposure to long-term growth opportunities, supporting innovation and technological development and driving revenue and sectoral diversification for the Kingdom of Saudi Arabia.\"</li><li>The ample funding from the Saudi wealth fund is of interest as well to EV players Volkswagen (<a href='https://seekingalpha.com/symbol/VWAGY' title='Volkswagen AG ADR'>OTCPK:VWAGY</a>), Audi (<a href='https://seekingalpha.com/symbol/AUDVF' title='Audi AG'>OTCPK:AUDVF</a>), Daimler (<a href='https://seekingalpha.com/symbol/DDAIF' title='Daimler AG'>OTCPK:DDAIF</a>) and BMW (<a href='https://seekingalpha.com/symbol/BMWYY' title='Bayerische Motoren Werke AG ADR'>OTCPK:BMWYY</a>). Automakers that could all be competing at similar price points in the luxury EV market in 2020 and beyond.</li><li>Shares of Tesla (NASDAQ:<a href='https://seekingalpha.com/symbol/TSLA' title='Tesla, Inc.'>TSLA</a>) are <font color='red'>down 2.12%</font> in premarket trading to $289.10.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3390700\" data-linked=\"Tesla drops after Lucid moment\" data-tweet=\"$VWAGY $VWAGY $AUDVF - Tesla drops after Lucid moment https://seekingalpha.com/news/3390700-tesla-drops-after-lucid-moment?source=tweet\" data-url=\"https://seekingalpha.com/news/3390700-tesla-drops-after-lucid-moment\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:25 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>107&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3390699\" data-ts=\"1537190687\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MYND\" target=\"_blank\">MYND</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3390699-premarket-gainers-of-9-05-09-17-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers as of 9:05 am (09/17/2018)</a></h4><ul><li><a href='https://seekingalpha.com/symbol/MYND' title='MYnd Analytics, Inc.'>MYND</a> <font color='green'>+42%</font>&nbsp;as FDA has granted Breakthrough Device designation for the Company&rsquo;s next generation product PEER 4.0.</li><li><a href='https://seekingalpha.com/symbol/SNMX' title='Senomyx, Inc.'>SNMX</a> <font color='green'>+42%</font>&nbsp;on being <a href=\"https://seekingalpha.com/news/3390674-firmenich-acquire-senomyx\" target=\"_blank\">acquired</a> by Firmenich.</li><li><a href='https://seekingalpha.com/symbol/NBEV' title='New Age Beverages Corporation'>NBEV</a> <font color='green'>+29%</font>&nbsp;as&nbsp;Coca-Cola is <a href=\"https://seekingalpha.com/news/3390653-new-age-beverages-tracks-higher\" target=\"_blank\">considering</a> a move into CBD wellness drinks.</li><li><a href='https://seekingalpha.com/symbol/CLRB' title='Cellectar Biosciences, Inc.'>CLRB</a> <font color='green'>+19%</font>&nbsp;on another RPDD tag for <a href=\"https://seekingalpha.com/news/3390679-cellectar-bio-24-percent-premarket-another-rpdd-tag-clr-131\" target=\"_blank\">CLR 131</a>.</li><li><a href='https://seekingalpha.com/symbol/NEPT' title='Neptune Wellness Solutions Inc.'>NEPT</a> <font color='green'>+18%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3390650-neptune-21-percent-receiving-confirmation-readiness-letter-health-canada\" target=\"_blank\">receiving </a>Confirmation of Readiness letter from Health Canada.</li><li><a href='https://seekingalpha.com/symbol/SIR' title='Select Income REIT'>SIR</a> <font color='green'>+16%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3390614-select-income-reit-jumps-merger-government-properties-income-trust\" target=\"_blank\">merger</a> with Government Properties Income Trust.</li><li><a href='https://seekingalpha.com/symbol/NEWA' title='Newater Technology, Inc.'>NEWA</a> <font color='green'>+14%</font>.</li><li><a href='https://seekingalpha.com/symbol/ABIL' title='Ability Inc.'>ABIL</a> <font color='green'>+13%</font>.</li><li><a href='https://seekingalpha.com/symbol/IGC' title='India Globalization Capital, Inc'>OTC:IGC</a> <font color='green'>+7%</font>.</li><li><a href='https://seekingalpha.com/symbol/TLRY' title='Tilray, Inc.'>TLRY</a> <font color='green'>+7%</font>.</li><li><a href='https://seekingalpha.com/symbol/TEVA' title='Teva Pharmaceutical Industries Limited'>TEVA</a> <font color='green'>+7%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3390660-premarket-analyst-action-healthcare\" target=\"_blank\">positive</a> analyst action.</li><li><a href='https://seekingalpha.com/symbol/QTT' title='Qutoutiao'>QTT</a> <font color='green'>+6%</font>.</li><li><a href='https://seekingalpha.com/symbol/ARGX' title='Argenx SE'>ARGX</a> <font color='green'>+7%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3390623-argenx-15-percent-premarket-positive-mid-stage-data-efgartigimod\" target=\"_blank\">positive</a> mid-stage data on efgartigimod.</li><li><a href='https://seekingalpha.com/symbol/BLDP' title='Ballard Power Systems, Inc.'>BLDP</a> <font color='green'>+5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3390699\" data-linked=\"Premarket Gainers as of 9:05 am (09/17/2018)\" data-tweet=\"$MYND $EMMA $SNMX - Premarket Gainers as of 9:05 am (09/17/2018) https://seekingalpha.com/news/3390699-premarket-gainers-of-9-05-09-17-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3390699-premarket-gainers-of-9-05-09-17-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:24 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3390698\" data-ts=\"1537190452\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IQ\" target=\"_blank\">IQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3390698-chinese-streaming-firms-dip-bytedance-reportedly-plans-rival-tv-entry\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Chinese streaming firms dip as ByteDance reportedly plans rival TV entry</a></h4><ul>    <li>Chinese video-streaming firms are trading lower in U.S. premarket action after a report of a new rival pushing into the market.</li>    <li>Beijing ByteDance plans to add <a href=\"https://www.scmp.com/tech/start-ups/article/2164304/bytedance-enter-chinas-long-form-streaming-video-market-challenging\" target=\"_blank\">new film and TV drama segments</a> to its Xigua Video app by early next year, according to the <i>South China Morning Post.</i></li>    <li>That means exclusive digital rights to some existing shows as well as a number of original film/TV projects, according to the report. The company is looking at a paid subscription model.</li>    <li>Along with Xigua, ByteDance runs the popular app Douyin (known outside China as Tik Tok), which has 15-second clips and is a go-to for China's Gen Z-ers posting video.</li>    <li>Lower this morning: iQiyi (NASDAQ:<a href='https://seekingalpha.com/symbol/IQ' title='iQIYI, Inc'>IQ</a>), <font color='red'>down 2.5%</font> premarket; Huya Broadcasting (NYSE:<a href='https://seekingalpha.com/symbol/HUYA' title='Huya Broadcasting'>HUYA</a>), <font color='red'>down 2.4%</font>; <a href='https://seekingalpha.com/symbol/YY' title='YY Inc.'>YY</a>, <font color='red'>down 1.9%</font>; Momo (NASDAQ:<a href='https://seekingalpha.com/symbol/MOMO' title='Momo'>MOMO</a>), <font color='red'>down 2.4%</font>; Bilibili (NASDAQ:<a href='https://seekingalpha.com/symbol/BILI' title='Bilibili'>BILI</a>), <font color='red'>down 1.6%</font>.</li>    <li>The new effort would compete also with Tencent Video and Youku Tudou; <a href='https://seekingalpha.com/symbol/TCEHY' title='Tencent Holding Ltd. ADR'>OTCPK:TCEHY</a> is <font color='red'>down 1.4%</font> premarket and Youku Tudou owner Alibaba (NYSE:<a href='https://seekingalpha.com/symbol/BABA' title='Alibaba Group Holding Limited'>BABA</a>) <font color='red'>down 1.9%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3390698\" data-linked=\"Chinese streaming firms dip as ByteDance reportedly plans rival TV entry\" data-tweet=\"$IQ $IQ $HUYA - Chinese streaming firms dip as ByteDance reportedly plans rival TV entry https://seekingalpha.com/news/3390698-chinese-streaming-firms-dip-bytedance-reportedly-plans-rival-tv-entry?source=tweet\" data-url=\"https://seekingalpha.com/news/3390698-chinese-streaming-firms-dip-bytedance-reportedly-plans-rival-tv-entry\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:20 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>50&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3390695\" data-ts=\"1537190356\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KMPH\" target=\"_blank\">KMPH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3390695-kempharm-on-go-u-s-filing-for-kp415-after-intranasal-hap-study-shares-up-8-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">KemPharm on go with U.S. filing for KP415 after intranasal HAP study; shares up 8% premarket</a></h4><ul><li>Thinly traded nano cap KemPharm (NASDAQ:<a href='https://seekingalpha.com/symbol/KMPH' title='KemPharm'>KMPH</a>) is up&nbsp;<font color='green'>8%</font>&nbsp;premarket on light volume on the heels of its <a href=\"https://seekingalpha.com/pr/17271172-kempharm-announces-positive-topline-results-intranasal-human-abuse-potential-trial-kp415\" target=\"_blank\">announcement </a>of the conclusion of an intranasal human abuse potential &#40;HAP&#41; study of ADHD candidate KP415 (serdexmethylphenidate or SDX).</li><li>The results showed significantly lower drug liking scores compared to intranasal d-methylphenidate hydrochloride, indicating that SDX is not efficiently converted to active d-methylphenidate when snorted.</li><li>The company says the key components of the data package supporting a U.S. marketing application are now complete and it expects to file an NDA as early as Q1 2019.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3389289-kempharm-prodrug-sdx-shows-lower-abuse-potential-study\" target=\"_blank\">KemPharm prodrug SDX shows lower abuse potential in study</a> (Sept. 11)</li></ul><div class=\"tiny-share-widget\" data-id=\"3390695\" data-linked=\"KemPharm on go with U.S. filing for KP415 after intranasal HAP study; shares up 8% premarket\" data-tweet=\"$KMPH - KemPharm on go with U.S. filing for KP415 after intranasal HAP study; shares up 8% premarket https://seekingalpha.com/news/3390695-kempharm-on-go-u-s-filing-for-kp415-after-intranasal-hap-study-shares-up-8-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3390695-kempharm-on-go-u-s-filing-for-kp415-after-intranasal-hap-study-shares-up-8-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:19 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3390692\" data-ts=\"1537190242\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NI\" target=\"_blank\">NI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3390692-nisource-continues-lower-after-new-gas-leak-detected-in-boston-area\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NiSource continues lower after new gas leak detected in Boston area</a></h4><ul>     <li>NiSource (NYSE:<a href='https://seekingalpha.com/symbol/NI' title='NiSource Inc.'>NI</a>) <font color='red'>-2.2%</font> pre-market after <a href=\"https://seekingalpha.com/news/3390542-nisource-closes-minus-12-percent-biggest-gas-pipeline-accident-since-2010\" target=\"_blank\">plunging nearly 12% on Friday</a> following the series of deadly gas explosions and fires in three towns near Boston that occurred after <a href=\"https://www.wsj.com/articles/residents-return-after-gas-line-caused-explosions-fires-1537118229\" target=\"_blank\">too much natural gas</a> was pumped into a section of pipe owned by the company's Columbia Gas subsidiary.</li>     <li>A <a href=\"https://www.cbsnews.com/news/new-gas-leak-reported-in-lawrence-massachusetts-today-2018-09-15/\" target=\"_blank\">new gas leak</a> was reported in Lawrence, Mass., on Saturday after an odor of gas was detected but was said to be unrelated to the previous explosions.</li>     <li>Eversource (NYSE:<a href='https://seekingalpha.com/symbol/ES' title='Eversource Energy'>ES</a>) says it will be weeks, not days, before gas service is fully restored in the region.</li>     <li>In a <a href=\"https://seekingalpha.com/pr/17270935-columbia-gas-massachusetts-commits-complete-replacement-merrimack-valley-gas-distribution\" target=\"_blank\">statement issued last night</a>, NiSource said it is developing a plan to \"replace the entire affected 48-mile cast iron and bare  steel pipeline system in the towns of Andover, Lawrence and North Andover with state-of-the-art plastic distribution mains and service lines, and modern safety features such as pressure regulation and excess flow valves at each premise.\"</li> </ul><div class=\"tiny-share-widget\" data-id=\"3390692\" data-linked=\"NiSource continues lower after new gas leak detected in Boston area\" data-tweet=\"$NI $NI $ES - NiSource continues lower after new gas leak detected in Boston area https://seekingalpha.com/news/3390692-nisource-continues-lower-after-new-gas-leak-detected-in-boston-area?source=tweet\" data-url=\"https://seekingalpha.com/news/3390692-nisource-continues-lower-after-new-gas-leak-detected-in-boston-area\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:17 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3390688\" data-ts=\"1537190133\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3390688-ares-managementplus-2_1-after-adding-two-portfolio-managers-to-credit-group\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ares Management +2.1% after adding two portfolio managers to credit group</a></h4><ul><li>Ares Management&nbsp;<font color='green'>rises 2.1%&nbsp;</font>in premarket trading after announcing Jason Duko and Kapil Singh are<a href=\"https://seekingalpha.com/pr/17271061-ares-management-adds-two-seasoned-portfolio-managers-credit-group\" target=\"_blank\"> joining as partners and portfolio managers </a>in the Ares Credit Group, focusing on liquid credit strategies.</li><li>The new appointments reflect Ares's push in below investment-grade credit.</li><li>Duko will be primarily responsible for managing U.S. bank loan strategies, while Singh will be responsible for managing U.S. high-yield bond strategies. Both will be members of the U.S. Liquid Credit Investment Committee.</li><li>Duko was most recently a portfolio manager at Pimco, where he managed bank loan assets across a range of investment strategies and was responsible for secondary loan trading.</li><li>Singh&nbsp; was most recently portfolio manager at DoubleLine Capital's global developed credit group, where he led the high-yield effort.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3388298-ares-management-acquires-paradigm-energy-partners\" target=\"_blank\">Ares Management acquires Paradigm Energy Partners</a> (Sept. 6)</li></ul><div class=\"tiny-share-widget\" data-id=\"3390688\" data-linked=\"Ares Management +2.1% after adding two portfolio managers to credit group\" data-tweet=\"Ares Management +2.1% after adding two portfolio managers to credit group https://seekingalpha.com/news/3390688-ares-managementplus-2_1-after-adding-two-portfolio-managers-to-credit-group?source=tweet\" data-url=\"https://seekingalpha.com/news/3390688-ares-managementplus-2_1-after-adding-two-portfolio-managers-to-credit-group\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:15 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3390685\" data-ts=\"1537189902\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PLAY\" target=\"_blank\">PLAY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3390685-analysts-see-vr-lift-for-dave-busters-entertainment\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Analysts see VR lift for Dave &amp; Buster&#39;s Entertainment</a></h4><ul> <li>Analysts are bumping up price targets on Dave &amp; Buster's Entertainment (NASDAQ:<a href='https://seekingalpha.com/symbol/PLAY' title='Dave & Buster&#39;s Entertainment, Inc.'>PLAY</a>) following the restaurant/entertainment chain's Q2 earnings topper.</li> <li>BMO moves to a price target of $70 on D&amp;B, while Wells Fargo takes it PT to $69 as it points to the potential for the virtual reality platform to grow.</li> <li>During Dave &amp; Buster's Q2 <a href=\"https://seekingalpha.com/article/4206391-dave-and-busters-entertainment-inc-play-ceo-brian-jenkins-q2-2018-results-earnings-call?part=single\" target=\"_blank\">earnings conference call</a>, execs said that they expect virtual reality games to provide a seocond-half comparable sales lift, although there is an expectation for a slight margin drag due to the new labor profile in the back half.</li> <li>PLAY <font color='green'>+0.85%</font> premarket to $62.85 to follow on Friday's 7.88% rally. The 52-week high on Dave &amp; Buster's is $62.86.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3390685\" data-linked=\"Analysts see VR lift for Dave &amp; Buster&#39;s Entertainment\" data-tweet=\"$PLAY - Analysts see VR lift for Dave &amp; Buster&#39;s Entertainment https://seekingalpha.com/news/3390685-analysts-see-vr-lift-for-dave-busters-entertainment?source=tweet\" data-url=\"https://seekingalpha.com/news/3390685-analysts-see-vr-lift-for-dave-busters-entertainment\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:11 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3390683\" data-ts=\"1537189797\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GOV-OLD\" target=\"_blank\">GOV-OLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3390683-premarket-losers-of-9-05-9-17-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Losers as of 9:05 am (9/17/2018)</a></h4><ul><li><a href='https://seekingalpha.com/symbol/GOV-OLD' title='Government Properties Income Trust'>GOV-OLD</a>&nbsp;<font color='red'>-14%</font>&nbsp;on announcing <a href=\"https://seekingalpha.com/news/3390614-select-income-reit-jumps-merger-government-properties-income-trust\" target=\"_blank\">merger</a> agreement.</li><li><a href='https://seekingalpha.com/symbol/TKC' title='Turkcell Iletisim Hizmetleri A.S.'>TKC</a> <font color='red'>-6%</font>.</li><li><a href='https://seekingalpha.com/symbol/NIO' title='NIO'>NIO</a> <font color='red'>-6%</font>.</li><li><a href='https://seekingalpha.com/symbol/MYSZ' title='MySize Inc.'>MYSZ</a> <font color='red'>-5%</font>.</li><li><a href='https://seekingalpha.com/symbol/LPL' title='LG Display Co., Ltd.'>LPL</a> <font color='red'>-5%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3390683\" data-linked=\"Premarket Losers as of 9:05 am (9/17/2018)\" data-tweet=\"$GOV-OLD $GOV-OLD $TKC - Premarket Losers as of 9:05 am (9/17/2018) https://seekingalpha.com/news/3390683-premarket-losers-of-9-05-9-17-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3390683-premarket-losers-of-9-05-9-17-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:09 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3390679\" data-ts=\"1537189585\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLRB\" target=\"_blank\">CLRB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3390679-cellectar-bio-up-24-premarket-on-another-rpdd-tag-for-clr-131\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cellectar Bio up 24% premarket on another RPDD tag for CLR 131</a></h4><ul><li>Thinly traded nano cap Cellectar Biosciences (NASDAQ:<a href='https://seekingalpha.com/symbol/CLRB' title='Cellectar Biosciences, Inc.'>CLRB</a>) is up&nbsp;<font color='green'>24%</font>&nbsp;premarket on increased volume in response to the FDA's <a href=\"http://globenewswire.com/news-release/2018/09/17/1571726/0/en/FDA-Grants-Rare-Pediatric-Disease-Designation-to-Cellectar-Biosciences-CLR-131-for-the-Treatment-of-Osteosarcoma.html\" target=\"_blank\">granting </a>of Rare Pediatric Disease Designation &#40;RPDD&#41; to CLR 131 for the treatment of a rare pediatric cancer called osteosarcoma, the fourth pediatric cancer so designated.</li><li>Among the benefits of the tag is the awarding of a priority review voucher, if the product is approved for the indication, that can be used for accelerated review of a future marketing application or sold to a third party.</li></ul><div class=\"tiny-share-widget\" data-id=\"3390679\" data-linked=\"Cellectar Bio up 24% premarket on another RPDD tag for CLR 131\" data-tweet=\"$CLRB - Cellectar Bio up 24% premarket on another RPDD tag for CLR 131 https://seekingalpha.com/news/3390679-cellectar-bio-up-24-premarket-on-another-rpdd-tag-for-clr-131?source=tweet\" data-url=\"https://seekingalpha.com/news/3390679-cellectar-bio-up-24-premarket-on-another-rpdd-tag-for-clr-131\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:06 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3390674\" data-ts=\"1537189347\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SNMX\" target=\"_blank\">SNMX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3390674-firmenich-to-acquire-senomyx\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Firmenich to acquire Senomyx</a></h4><ul> <li>Senomyx (NASDAQ:<a href='https://seekingalpha.com/symbol/SNMX' title='Senomyx, Inc.'>SNMX</a>) soars after agreeing to a deal to be acquired by Firmenich for $1.50 per share in cash.</li><li>The transaction has already been approved by the boards of both companies.</li><li>The merger is expected to close in Q4.</li> <li>Deal details: \"Senomyx will be integrated into Firmenich's North America Research &amp; Development organization and its products will be commercialized through its Taste Platform. Senomyx R&amp;D operations will remain in San Diego, with a continued focus on discovering and developing world-class flavor and sweetener solutions for the world's greatest brands.\"</li>  <li>SNMX  <font color='green'>+41.91%</font> premarket to  $1.49.</li><li>Source: <a href=\"https://seekingalpha.com/pr/17271047-firmenich-acquire-senomyx-pioneer-taste-innovation\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3390674\" data-linked=\"Firmenich to acquire Senomyx\" data-tweet=\"$SNMX - Firmenich to acquire Senomyx https://seekingalpha.com/news/3390674-firmenich-to-acquire-senomyx?source=tweet\" data-url=\"https://seekingalpha.com/news/3390674-firmenich-to-acquire-senomyx\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:02 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3390670\" data-ts=\"1537189151\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MRSN\" target=\"_blank\">MRSN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3390670-fda-lifts-partial-clinical-hold-on-mersanas-xmtminus-1522-shares-ahead-8-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA lifts partial clinical hold on Mersana&#39;s XMT-1522; shares ahead 8% premarket</a></h4><ul><li>Mersana Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/MRSN' title='Mersana Therapeutics'>MRSN</a>) <a href=\"https://seekingalpha.com/pr/17271128-mersana-announces-fda-lifts-partial-clinical-hold-xmtminus-1522\" target=\"_blank\">announces</a> that the FDA has lifted the partial clinical hold on the Phase 1 study of XMT-1522.</li>   <li>Mersana and the FDA reached alignment on changes to the protocol, including increased monitoring as well as the exclusion of patients with advanced hepatic impairment. Mersana has also decided to implement similar modifications to the XMT-1536 protocol.</li>  <li>In addition, alternative dosing regimens will be evaluated for both clinical trials. The XMT-1522 trial will begin with a once-every-four-week dose regimen. This dosing regimen has already been implemented in the XMT-1536 trial.</li><li>The company may evaluate additional regimens as well.&nbsp; Data on XMT-1536 is expected in H1 2019.</li><li>Shares are up&nbsp;<font color='green'>8%</font>&nbsp;premarket.</li><li><strong>Update</strong>: Shares are down&nbsp;<font color='red'>13%</font>&nbsp;on modestly higher volume two hours into the session.</li>      </ul><div class=\"tiny-share-widget\" data-id=\"3390670\" data-linked=\"FDA lifts partial clinical hold on Mersana&#39;s XMT-1522; shares ahead 8% premarket\" data-tweet=\"$MRSN - FDA lifts partial clinical hold on Mersana&#39;s XMT-1522; shares ahead 8% premarket https://seekingalpha.com/news/3390670-fda-lifts-partial-clinical-hold-on-mersanas-xmtminus-1522-shares-ahead-8-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3390670-fda-lifts-partial-clinical-hold-on-mersanas-xmtminus-1522-shares-ahead-8-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:59 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3390667\" data-ts=\"1537188847\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ACB\" target=\"_blank\">ACB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3390667-aurora-cannabis-up-15-premarket-on-talks-coca-cola-on-cbd-drinks\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aurora Cannabis up 15% premarket on talks with Coca-Cola on CBD drinks</a></h4><ul><li>Aurora Cannabis (ACBFF) is up&nbsp;<font color='green'>15%</font>&nbsp;premarket on light volume on the heels of a Bloomberg <a href=\"https://www.bloomberg.com/news/articles/2018-09-17/coca-cola-eyes-cannabis-market-in-push-beyond-sluggish-sodas\" target=\"_blank\">report</a> that it is in talks with Coca-Cola (NYSE:<a href='https://seekingalpha.com/symbol/KO' title='The Coca-Cola Company'>KO</a>) aimed at developing cannabinoid-infused drinks (non-psychoactive ingredient in marijuana).</li><li>Molson Coors Brewing (NYSE:<a href='https://seekingalpha.com/symbol/TAP' title='Molson Coors Brewing Company'>TAP</a>) is starting a joint venture in Canada with Hydropothecary Corp. to develop cannabis drinks there. Diageo PLC (NYSE:<a href='https://seekingalpha.com/symbol/DEO' title='Diageo plc'>DEO</a>) is in talks with at least three Canadian cannabis producers about a possible deal.</li><li>Tilray (NASDAQ:<a href='https://seekingalpha.com/symbol/TLRY' title='Tilray, Inc.'>TLRY</a>) is up&nbsp;<font color='green'>7%</font>&nbsp;premarket. Cronos Group (NASDAQ:<a href='https://seekingalpha.com/symbol/CRON' title='Cronos Group, Inc.'>CRON</a>) and Canopy Growth (NYSE:<a href='https://seekingalpha.com/symbol/CGC' title='Canopy Growth Corporation'>CGC</a>) are up&nbsp;<font color='green'>2%</font>.</li><li><strong>Update</strong>: Today, September 19, ACBFF sasy its policy is not to comment on speculative news reports but confirms that it engages in \"exploratory discussions\" with industry participants from time to time, although there is no agreement or understanding about any partnership with a beverage company.</li></ul><div class=\"tiny-share-widget\" data-id=\"3390667\" data-linked=\"Aurora Cannabis up 15% premarket on talks with Coca-Cola on CBD drinks\" data-tweet=\"$ACB $ACB $KO - Aurora Cannabis up 15% premarket on talks with Coca-Cola on CBD drinks https://seekingalpha.com/news/3390667-aurora-cannabis-up-15-premarket-on-talks-coca-cola-on-cbd-drinks?source=tweet\" data-url=\"https://seekingalpha.com/news/3390667-aurora-cannabis-up-15-premarket-on-talks-coca-cola-on-cbd-drinks\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:54 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>114&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3390660\" data-ts=\"1537188119\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AVRO\" target=\"_blank\">AVRO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3390660-premarket-analyst-action-healthcare\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket analyst action - healthcare</a></h4><ul><li>AVROBIO (NASDAQ:<a href='https://seekingalpha.com/symbol/AVRO' title='AVROBIO'>AVRO</a>) initiated with Buy rating and $47 (18% upside) price target at H.C. Wainwright citing the success of peer bluebird bio in childhood adrenoleukodystrophy.</li><li>Puma Biotechnology (NYSE:<a href='https://seekingalpha.com/symbol/PBYI' title='Puma Biotechnology, Inc.'>PBYI</a>) initiated with Sell rating and $42 (11% downside risk) price target at Goldman Sachs. Shares down&nbsp;<font color='red'>4%</font>&nbsp;premarket.</li><li>Anthem (NYSE:<a href='https://seekingalpha.com/symbol/ANTM' title='Anthem, Inc.'>ANTM</a>) initiated with Outperform rating and $318 (17% upside) price target at Cowen and Company.</li><li>Immunomedics (NASDAQ:<a href='https://seekingalpha.com/symbol/IMMU' title='Immunomedics, Inc.'>IMMU</a>) initiated with Buy rating and $36 (62% upside) price target at Goldman.</li><li>Loxo Oncology (NASDAQ:<a href='https://seekingalpha.com/symbol/LOXO' title='Loxo Oncology'>LOXO</a>) initiated with Neutral rating and $165 (flat) price target at Goldman.</li><li>Exelixis (NASDAQ:<a href='https://seekingalpha.com/symbol/EXEL' title='Exelixis, Inc.'>EXEL</a>) initiated with Neutral rating and $22 (29% upside) price target at Goldman.</li><li>Teva Pharmaceutical Industries (NYSE:<a href='https://seekingalpha.com/symbol/TEVA' title='Teva Pharmaceutical Industries Limited'>TEVA</a>) upgraded to Neutral at BTIG Research following FDA nod for migraine med AJOVY. Shares up&nbsp;<font color='green'>7%</font>&nbsp;premarket.</li><li>Cigna (NYSE:<a href='https://seekingalpha.com/symbol/CI' title='Cigna Corporation'>CI</a>) initiated with Outperform rating and $240 (23% upside) price target at Cowen.</li><li>UnitedHealth Group (NYSE:<a href='https://seekingalpha.com/symbol/UNH' title='UnitedHealth Group Inc.'>UNH</a>) initiated with Outperform rating and $308 (16% upside) at Cowen.</li><li>Humana (NYSE:<a href='https://seekingalpha.com/symbol/HUM' title='Humana Inc.'>HUM</a>) initiated with Market Perform rating and $372 (13% upside) price target at Cowen.</li><li>Revance Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/RVNC' title='Revance Therapeutics, Inc.'>RVNC</a>) downgraded to Market Perform at JMP Securities. Shares down&nbsp;<font color='red'>5%&nbsp;</font>premarket following Allergan's bullish presentation on its aesthetics business.</li><li>Thermo Fisher Scientific (NYSE:<a href='https://seekingalpha.com/symbol/TMO' title='Thermo Fisher Scientific Inc.'>TMO</a>) downgraded to Neutral and removed from the Conviction Buy List at Goldman.</li></ul><div class=\"tiny-share-widget\" data-id=\"3390660\" data-linked=\"Premarket analyst action - healthcare\" data-tweet=\"$AVRO $AVRO $PBYI - Premarket analyst action - healthcare https://seekingalpha.com/news/3390660-premarket-analyst-action-healthcare?source=tweet\" data-url=\"https://seekingalpha.com/news/3390660-premarket-analyst-action-healthcare\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:41 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3390654\" data-ts=\"1537187816\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MU\" target=\"_blank\">MU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3390654-deutsche-bank-lowers-microns-target-ahead-of-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Deutsche Bank lowers Micron&#39;s target ahead of earnings</a></h4><ul><li>Deutsche Bank <a href=\"https://www.streetinsider.com/Analyst+Comments/Micron+Technology+%28MU%29+PT+Lowered+to+%2460+at+Deutsche+Bank%3B+Pricing+Pressures+to+Sustain+for+Next+Few+Quarters/14612233.html\" target=\"_blank\">lowers</a> its Micron (NASDAQ:<a href='https://seekingalpha.com/symbol/MU' title='Micron Technology Inc.'>MU</a>) target from $80 to $60, a 35% upside to Friday&rsquo;s close.</li><li>The firm adjusts ahead of Micron&rsquo;s Q4 report on September 20 and lowers its Q1 and FY19 estimates to reflect the recent deterioration of NAND and DRAM pricing.</li><li>Rating reiterated at Buy.</li><li>Micron shares are&nbsp;<font color='red'>down 1.8%</font>&nbsp;premarket to $43.50.</li><li>        Update with Deutsche Bank&rsquo;s <a href=\"https://www.cnbc.com/2018/09/17/two-top-brokerages-cut-micron-target-by-25percent-ahead-of-earnings.html\" target=\"_blank\">color</a>:</li><li>               Analyst Sidney Ho cites the &ldquo;deterioration&rdquo; of memory chip pricing and cuts the firm&rsquo;s EPS estimates by 6% for Q1 and 20% for FY19.&nbsp;</li><li>               Ho: &ldquo;While we do expect MU&rsquo;s share price to be choppy in the near term, we also see rational capital spending by other memory suppliers leading to quicker stabilization of the market than previous cycles.&rdquo;&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3390654\" data-linked=\"Deutsche Bank lowers Micron&#39;s target ahead of earnings\" data-tweet=\"$MU - Deutsche Bank lowers Micron&#39;s target ahead of earnings https://seekingalpha.com/news/3390654-deutsche-bank-lowers-microns-target-ahead-of-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/3390654-deutsche-bank-lowers-microns-target-ahead-of-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:36 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>94&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3390650\" data-ts=\"1537187699\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NEPT\" target=\"_blank\">NEPT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3390650-neptune-up-21-on-receiving-confirmation-of-readiness-letter-from-health-canada\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Neptune up 21% on receiving Confirmation of Readiness letter from Health Canada</a></h4><ul> <li>Neptune Technologies &amp; Bioressources (NASDAQ:<a href='https://seekingalpha.com/symbol/NEPT' title='Neptune Wellness Solutions Inc.'>NEPT</a>) has <a href=\"https://seekingalpha.com/pr/17271100-neptune-receives-confirmation-readiness-letter-health-canada\" target=\"_blank\">received</a> a Confirmation of Readiness letter from Health Canada in regard to its application to become a Licensed Producer under the ACMPR (Access to Cannabis for Medical Purposes Regulations).</li> <li>Health Canada's positive response marks another important regulatory step forward to obtaining Neptune's licence to produce cannabis oil supporting to commence commercialization this fiscal year.</li><li>Neptune will notify Health Canada in the coming days and provide all additional required evidence to the agency to demonstrate the Corporation's readiness to commence production. Upon satisfactory review by Health Canada, the Corporation would receive its licence for cannabis extraction.</li> <li>Shares are up&nbsp;<font color='green'>21%</font>&nbsp;premarket.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3390650\" data-linked=\"Neptune up 21% on receiving Confirmation of Readiness letter from Health Canada\" data-tweet=\"$NEPT - Neptune up 21% on receiving Confirmation of Readiness letter from Health Canada https://seekingalpha.com/news/3390650-neptune-up-21-on-receiving-confirmation-of-readiness-letter-from-health-canada?source=tweet\" data-url=\"https://seekingalpha.com/news/3390650-neptune-up-21-on-receiving-confirmation-of-readiness-letter-from-health-canada\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:34 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3390645\" data-ts=\"1537187136\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TWTR\" target=\"_blank\">TWTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3390645-moffettnathanson-lowers-twitter-target-to-30-downside\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MoffettNathanson lowers Twitter target to 30% downside</a></h4><ul><li>MoffettNathanson <a href=\"https://www.streetinsider.com/Analyst+Comments/Twitter%2C+Inc.+%28TWTR%29+PT+Lowered+to+%2421+at+MoffettNathanson/14612447.html\" target=\"_blank\">lowers</a> its Twitter (NYSE:<a href='https://seekingalpha.com/symbol/TWTR' title='Twitter, Inc.'>TWTR</a>) target from $23 to $21, a 30% downside to Friday&rsquo;s close.</li><li>Rating maintained at Sell.</li><li>Twitter shares are&nbsp;<font color='red'>down 1.7%</font>&nbsp;premarket to $29.61.</li><li>        Update with color from analyst Michael Nathanson (source: Bloomberg First Word):&nbsp;</li><li>        Nathanson says analysts seem to underestimate Twitter&rsquo;s expense build and will likely need to lower margin forecasts in 2019.&nbsp;</li><li>        He calls operating expense growth &ldquo;amazingly low&rdquo; for the first two quarters of the year.&nbsp;</li><li>        Nathanson expects expenses to rise into the end of 2018 and into 2019 given Twitter&rsquo;s &ldquo;dire need&rdquo; to improve the platform&rsquo;s safety and to spend more time on video. &nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3390645\" data-linked=\"MoffettNathanson lowers Twitter target to 30% downside\" data-tweet=\"$TWTR - MoffettNathanson lowers Twitter target to 30% downside https://seekingalpha.com/news/3390645-moffettnathanson-lowers-twitter-target-to-30-downside?source=tweet\" data-url=\"https://seekingalpha.com/news/3390645-moffettnathanson-lowers-twitter-target-to-30-downside\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:25 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>22&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3390640\" data-ts=\"1537186562\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NXPI\" target=\"_blank\">NXPI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3390640-bofaml-steps-off-nxp-semi-sidelines\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BofAML steps off NXP Semi sidelines</a></h4><ul><li>        Bank of America Merrill Lynch <a href=\"https://www.streetinsider.com/Analyst+Comments/BofAMerrill+Lynch+Upgrades+NXP+Semiconductors+NV+%28NXPI%29+to+Buy/14612740.html\" target=\"_blank\">upgrades</a> NXP Semiconductors (NASDAQ:<a href='https://seekingalpha.com/symbol/NXPI' title='NXP Semiconductors'>NXPI</a>) from Neutral to Buy with a $120 price target, a 29% upside to Friday&rsquo;s close.</li><li>               NXP shares are&nbsp;<font color='green'>up 2.5%</font>&nbsp;premarket to $95.04.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3390640\" data-linked=\"BofAML steps off NXP Semi sidelines\" data-tweet=\"$NXPI - BofAML steps off NXP Semi sidelines https://seekingalpha.com/news/3390640-bofaml-steps-off-nxp-semi-sidelines?source=tweet\" data-url=\"https://seekingalpha.com/news/3390640-bofaml-steps-off-nxp-semi-sidelines\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:16 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3390635\" data-ts=\"1537186153\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MCHP\" target=\"_blank\">MCHP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3390635-bofaml-steps-to-microchip-sidelines\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BofAML steps to Microchip sidelines</a></h4><ul><li>        Bank of America Merrill Lynch downgrades Microchip (NASDAQ:<a href='https://seekingalpha.com/symbol/MCHP' title='Microchip Technology Incorporated'>MCHP</a>) to Neutral with&nbsp; $95 price target, a 14% upside to Friday&rsquo;s close.&nbsp;</li><li>               Source: Bloomberg First Word. &nbsp;&nbsp;</li><li>               Microchip shares are&nbsp;<font color='red'>down 1.9%</font>&nbsp;premarket to $82.&nbsp;&nbsp;&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3390635\" data-linked=\"BofAML steps to Microchip sidelines\" data-tweet=\"$MCHP - BofAML steps to Microchip sidelines https://seekingalpha.com/news/3390635-bofaml-steps-to-microchip-sidelines?source=tweet\" data-url=\"https://seekingalpha.com/news/3390635-bofaml-steps-to-microchip-sidelines\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:09 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3390634\" data-ts=\"1537186060\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BBBY\" target=\"_blank\">BBBY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3390634-bed-bath-beyond-higher-after-upgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bed Bath &amp; Beyond higher after upgrade</a></h4><ul> <li>Raymond James <a href=\"https://www.cnbc.com/2018/09/17/stocks-making-the-biggest-move-premarket-dwdp-axp-bbby-lulu-tsla--more.html?__source=newsletter%7Cbreakingnews\" target=\"_blank\">lifts</a> Bed Bath &amp; Beyond (NASDAQ:<a href='https://seekingalpha.com/symbol/BBBY' title='Bed Bath & Beyond Inc.'>BBBY</a>) to a Market Perform rating after having the retailer set at Underperform.</li> <li>The investment firm sees upside for Bed Bath &amp; Byond's sales track amid the generally improved consumer spending backdrop.</li> <li>Shares of BBBY are <font color='green'>up 3.49%</font> in premarket trading to $18.70 vs. the 52-week trading range of $16.52 to $28.94.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3390634\" data-linked=\"Bed Bath &amp; Beyond higher after upgrade\" data-tweet=\"$BBBY - Bed Bath &amp; Beyond higher after upgrade https://seekingalpha.com/news/3390634-bed-bath-beyond-higher-after-upgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3390634-bed-bath-beyond-higher-after-upgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:07 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3390633\" data-ts=\"1537185996\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BTX\" target=\"_blank\">BTX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3390633-biotime-updates-timeline-for-distribution-of-agex-shares-to-biotime-shareholders\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BioTime updates timeline for distribution of AgeX shares to Biotime shareholders</a></h4><ul> <li>BioTime (NYSEMKT:<a href='https://seekingalpha.com/symbol/BTX' title='BioTime, Inc'>BTX</a>) <a href=\"https://seekingalpha.com/pr/17270959-biotime-updates-timeline-distribution-agex-shares-biotime-shareholders\" target=\"_blank\">announces</a> that its Board       of Directors intends to set a new record date for the distribution of       AgeX Therapeutics shares to BioTime&nbsp;shareholders.</li><li>The       ratio of one share of AgeX common stock for every 10 shares of BioTime       common stock will remain unchanged. A new date provides time to complete       necessary administrative activities and receive all regulatory approvals.</li><li>BTX shares are up&nbsp;<font color='green'>3%</font>&nbsp;premarket.</li>                              </ul><div class=\"tiny-share-widget\" data-id=\"3390633\" data-linked=\"BioTime updates timeline for distribution of AgeX shares to Biotime shareholders\" data-tweet=\"$BTX $LCTX - BioTime updates timeline for distribution of AgeX shares to Biotime shareholders https://seekingalpha.com/news/3390633-biotime-updates-timeline-for-distribution-of-agex-shares-to-biotime-shareholders?source=tweet\" data-url=\"https://seekingalpha.com/news/3390633-biotime-updates-timeline-for-distribution-of-agex-shares-to-biotime-shareholders\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:06 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3390625\" data-ts=\"1537185199\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JD\" target=\"_blank\">JD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3390625-jd-comminus-3-on-morgan-stanley-target-cut\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">JD.com -3% on Morgan Stanley target cut</a></h4><ul><li>        Morgan Stanley lowers its JD.com (NASDAQ:<a href='https://seekingalpha.com/symbol/JD' title='JD.com'>JD</a>) price target from $37 to a Street-low $25 citing risk to near-term earnings and margins.&nbsp;</li><li>                  Analyst Grace Chen says JD&rsquo;s slowing GMV growth, lighter margins, and accelerated investments will weight down earnings for the rest of this year and into 2019.    </li><li>               Rating reaffirmed at Equal Weight due to the potential for long-term growth.&nbsp;</li><li>               Source: Bloomberg First Word.&nbsp;</li><li>               JD.com shares are&nbsp;<font color='red'>down 3.2%</font>&nbsp;premarket to $26.25.&nbsp;&nbsp;</li><li>        Alibaba (NYSE:<a href='https://seekingalpha.com/symbol/BABA' title='Alibaba Group Holding Limited'>BABA</a>) and Baidu (NASDAQ:<a href='https://seekingalpha.com/symbol/BIDU' title='Baidu, Inc.'>BIDU</a>) are&nbsp;<font color='red'>down 1.7%</font>&nbsp;and&nbsp;<font color='red'>1.4%</font>, respectively, after mainland China stocks closed at the lowest levels in four years.&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3390625\" data-linked=\"JD.com -3% on Morgan Stanley target cut\" data-tweet=\"$JD $JD $BABA - JD.com -3% on Morgan Stanley target cut https://seekingalpha.com/news/3390625-jd-comminus-3-on-morgan-stanley-target-cut?source=tweet\" data-url=\"https://seekingalpha.com/news/3390625-jd-comminus-3-on-morgan-stanley-target-cut\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:53 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>61&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3390623\" data-ts=\"1537185112\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARGX\" target=\"_blank\">ARGX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3390623-argenx-up-15-premarket-on-positive-mid-stage-data-on-efgartigimod\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Argenx up 15% premarket on positive mid-stage data on efgartigimod</a></h4><ul><li>Thinly traded argenx (NASDAQ:<a href='https://seekingalpha.com/symbol/ARGX' title='Argenx SE'>ARGX</a>) is up&nbsp;<font color='green'>15%</font>&nbsp;premarket on light volume on the heels of its <a href=\"https://www.sec.gov/Archives/edgar/data/1697862/000110465918057029/a18-31010_1ex99d1.htm\" target=\"_blank\">announcement </a>of positive results from a 38-subject Phase 2 clinical trial evaluating ARGX-113 (efgartigimod) in adult patients with immune thrombocytopenia &#40;ITP&#41;.</li><li>The primary endpoint was safety and tolerability, with efgartigimod demonstrating a profile consistent with earlier studies.</li><li>46% of patients in each of the 5 mg/kg and 10 mg/kg dosing cohorts experienced increases in platelet count to at least 50x10(9)/L (normal range is 150 - 450&nbsp;x10(9)/L) compared to 25% for placebo. The average duration of response in the responder group was 40 days versus 16 days for placebo.</li><li>The company plans to advance efgartigimod into Phase 3 development for ITP. It also plans to launch a Phase 2 study assessing a subcutaneous formulation. A Phase 3 study in myasthenia gravis and a Phase 2 in pemphigus vulgaris are ongoing.</li><li>Management will host a conference call this morning at 8:00 am ET to discuss the results.</li></ul><div class=\"tiny-share-widget\" data-id=\"3390623\" data-linked=\"Argenx up 15% premarket on positive mid-stage data on efgartigimod\" data-tweet=\"$ARGX - Argenx up 15% premarket on positive mid-stage data on efgartigimod https://seekingalpha.com/news/3390623-argenx-up-15-premarket-on-positive-mid-stage-data-on-efgartigimod?source=tweet\" data-url=\"https://seekingalpha.com/news/3390623-argenx-up-15-premarket-on-positive-mid-stage-data-on-efgartigimod\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:51 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3390608\" data-ts=\"1537182947\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AVGO\" target=\"_blank\">AVGO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3390608-nomura-upgrades-broadcom-to-27-upside\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nomura upgrades Broadcom to 27% upside</a></h4><ul><li>        Nomura Instinet upgrades Broadcom (NASDAQ:<a href='https://seekingalpha.com/symbol/AVGO' title='Broadcom Limited'>AVGO</a>) from Neutral to Buy with a $300 price target, a 27% upside to Friday&rsquo;s close. &nbsp;</li><li>        The firm cites a more constructive view of the CA acquisition, updated wireless guidance, and expectations for a significant hike in dividend.</li><li>               Sources: StreetAccount/<a href=\"https://www.streetinsider.com/Analyst+Comments/NomuraInstinet+Upgrades+Broadcom+Limited+%28AVGO%29+to+Buy/14612270.html\" target=\"_blank\">StreetInsider</a>&nbsp;</li><li>               Broadcom shares are&nbsp;<font color='green'>up 1.1%</font>&nbsp;premarket to $239.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3390608\" data-linked=\"Nomura upgrades Broadcom to 27% upside\" data-tweet=\"$AVGO - Nomura upgrades Broadcom to 27% upside https://seekingalpha.com/news/3390608-nomura-upgrades-broadcom-to-27-upside?source=tweet\" data-url=\"https://seekingalpha.com/news/3390608-nomura-upgrades-broadcom-to-27-upside\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:15 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":67,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}